<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">103783</article-id><article-id pub-id-type="doi">10.7554/eLife.103783</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.103783.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>NR2F2 is required in the embryonic testis for fetal Leydig cell development</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Perea-Gomez</surname><given-names>Aitana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7788-038X</contrib-id><email>Aitana.PEREA-GOMEZ@univ-cotedazur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bellido Carreras</surname><given-names>Natividad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1207-0711</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Dhellemmes</surname><given-names>Magali</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7983-3221</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Furong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7546-7500</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Le Gallo</surname><given-names>Coralie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0000-5079-4791</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chaboissier</surname><given-names>Marie-Christine</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0934-8217</contrib-id><email>marie-christine.chaboissier@univ-cotedazur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/019tgvf94</institution-id><institution>Université Côte d'Azur, CNRS, INSERM, iBV</institution></institution-wrap><addr-line><named-content content-type="city">Nice</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0243gzr89</institution-id><institution>Max Planck Institute for Biology Tübingen</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0243gzr89</institution-id><institution>Max Planck Institute for Biology Tübingen</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>10</day><month>07</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP103783</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-11-19"><day>19</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-09-25"><day>25</day><month>09</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.07.17.602099"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-01-03"><day>03</day><month>01</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.103783.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-10"><day>10</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.103783.2"/></event></pub-history><permissions><copyright-statement>© 2025, Perea-Gomez et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Perea-Gomez et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-103783-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-103783-figures-v1.pdf"/><abstract><p>Male genital development in XY mammalian fetuses is triggered by the action of hormones, including testosterone, secreted by the developing testes. Defects in this process are a cause for differences in sex development (DSD), one of the most common congenital abnormalities in humans. Fetal Leydig cells (FLCs) play a central role in the synthesis of masculinizing hormones in the developing testes. Yet, the genetic cascade controlling their differentiation is poorly understood. Here, we investigate the role of the orphan nuclear receptor NR2F2 (COUP-TFII) in FLC development. We report that NR2F2 is expressed in interstitial progenitor cells of the mouse embryonic testes and is downregulated upon their differentiation into FLC. By using two mouse models for conditional mutation of <italic>Nr2f2</italic> in the developing testes, we demonstrate that NR2F2 is required for testis morphogenesis and FLC development. NR2F2 acts in interstitial progenitors to regulate the initiation and progression of FLC differentiation. These results establish NR2F2 as an essential regulator of FLC development and steroid hormone synthesis in the mouse fetal testis and provide an entry point in understanding the etiology of 46,XY DSD associated with pathogenic NR2F2 variants.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>NR2F2</kwd><kwd>Leydig</kwd><kwd>steroidogenesis</kwd><kwd>testis</kwd><kwd>mouse</kwd><kwd>embryo</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-23-CE14-0012</award-id><principal-award-recipient><name><surname>Chaboissier</surname><given-names>Marie-Christine</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Tang</surname><given-names>Furong</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>Heterosex</award-id><principal-award-recipient><name><surname>Chaboissier</surname><given-names>Marie-Christine</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>NR2F2 regulates fetal Leydig cell differentiation and steroidogenesis in mouse testes, providing mechanistic insight into testis development and the etiology of 46,XY differences in sex development.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Sexual development in mammals is conditioned by the gonadal sex established during fetal life. In XY embryos, the initially undifferentiated gonads develop into testes that can produce testosterone which stimulates the differentiation of male internal and external genitalia (including epididymis, vas deferens, seminal vesicles, scrotum, and penis) leading to the masculinization of the fetus. In contrast, fetal ovaries do not produce testosterone, and female internal and external genitalia (oviducts, uterus, vagina, and vulva) develop in XX individuals. Abnormalities in the masculinization process are mainly associated with defects in androgen synthesis or signaling (<xref ref-type="bibr" rid="bib56">Reyes et al., 2023</xref>). Although this molecular cascade is well defined, the differentiation of androgen-producing cells in the embryo is only partially understood.</p><p>Androgen production in the developing testis relies mainly on fetal Leydig cells (FLCs), which express all enzymes required for the biosynthesis of androstenedione from cholesterol (<xref ref-type="bibr" rid="bib45">Miyabayashi et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Shima et al., 2013</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>). The final step of conversion of androstenedione into testosterone, catalyzed by HSD17B3, takes place in a different cell type, the fetal Sertoli cells (<xref ref-type="bibr" rid="bib62">Shima et al., 2013</xref>; <xref ref-type="bibr" rid="bib49">O’Shaughnessy et al., 2000</xref>). In addition to their role in androgen synthesis, FLCs also produce INSL3, a hormone required for testis descent (<xref ref-type="bibr" rid="bib47">Nef and Parada, 1999</xref>; <xref ref-type="bibr" rid="bib81">Zimmermann et al., 1999</xref>). Defects in testis descent, regulated also by androgens, result in cryptorchidism, a condition which impacts fertility and constitutes a risk factor for testicular cancer (<xref ref-type="bibr" rid="bib25">Hutson et al., 2015</xref>). While a fraction of FLCs persist after birth, others de-differentiate or involute, and adult testosterone production is ensured by a distinct population of steroidogenic cells, the adult Leydig cells (ALCs), which differentiate at puberty (<xref ref-type="bibr" rid="bib63">Shima and Morohashi, 2017</xref>; <xref ref-type="bibr" rid="bib65">Shima, 2019</xref>).</p><p>FLCs differentiate from embryonic day 12.5 (E12.5) in mice and increase in number during fetal life through the recruitment and differentiation of <italic>Wnt5a</italic> positive proliferative progenitors located in the interstitial space of the testes (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib63">Shima and Morohashi, 2017</xref>; <xref ref-type="bibr" rid="bib65">Shima, 2019</xref>; <xref ref-type="bibr" rid="bib57">Rotgers et al., 2018</xref>). Interstitial progenitors also give rise to the contractile peritubular myoid cells (PTM) that will surround the future seminiferous tubules (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>). Despite being the most abundant cell population in the fetal testis (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Mayère et al., 2022</xref>), little is known about the genetic control of the proliferation, specification, and differentiation of the interstitial steroidogenic progenitor cells.</p><p>Lineage tracing and single-cell transcriptomic analyses have revealed that interstitial progenitors have a dual origin. The majority are derived from the coelomic epithelium of the undifferentiated gonad, which harbors early bipotential progenitors able to differentiate along the supporting (the future Sertoli cells) or the steroidogenic lineage (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Karl and Capel, 1998</xref>; <xref ref-type="bibr" rid="bib66">Stévant et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Stévant et al., 2019</xref>). In addition, Nestin positive cells migrate from the adjacent mesonephros into the gonad and differentiate along the steroidogenic lineage from E13.5 to give rise to up to a third of the FLC population by the end of gestation (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib18">DeFalco et al., 2011</xref>; <xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>).</p><p>Positive and negative paracrine signals drive FLC differentiation by upregulating the transcription factors NR5A1, GATA4, and GATA6, which in turn regulate the expression of genes related to cholesterol metabolism and steroidogenesis (<xref ref-type="bibr" rid="bib57">Rotgers et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Wen et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Morohashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Baba et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Baba et al., 2014</xref>; <xref ref-type="bibr" rid="bib64">Shima et al., 2018</xref>; <xref ref-type="bibr" rid="bib50">Padua et al., 2015</xref>; <xref ref-type="bibr" rid="bib10">Bielinska et al., 2007</xref>; <xref ref-type="bibr" rid="bib73">Viger et al., 2022</xref>). Desert Hedgehog (DHH) is secreted by Sertoli cells and acts on the interstitial progenitors expressing the Hedgehog receptor Patched1 (PTCH1) and the Hedgehog effectors GLI1, -2, and -3 to trigger FLC and PTM differentiation (<xref ref-type="bibr" rid="bib76">Yao et al., 2002</xref>; <xref ref-type="bibr" rid="bib8">Barsoum and Yao, 2011</xref>; <xref ref-type="bibr" rid="bib7">Barsoum et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Park et al., 2000</xref>; <xref ref-type="bibr" rid="bib31">Kothandapani et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">Pierucci-Alves et al., 2001</xref>; <xref ref-type="bibr" rid="bib15">Clark et al., 2000</xref>). In addition, FLC development requires the activation of signaling pathways downstream of PDGFRA in the steroidogenic progenitors (<xref ref-type="bibr" rid="bib12">Brennan et al., 2003</xref>; <xref ref-type="bibr" rid="bib27">Inoue et al., 2022</xref>; <xref ref-type="bibr" rid="bib59">Schmahl et al., 2008</xref>). On the other hand, ligands present in vascular and perivascular cells activate the NOTCH2 receptor and the expression of the effectors HES1 and HEYL in interstitial progenitors to maintain their undifferentiated state and inhibit FLC differentiation (<xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="bibr" rid="bib70">Tang et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Defalco et al., 2013</xref>). In addition to the paracrine signals from adjacent cell populations, FLC differentiation is also regulated by the cell-autonomous action of the transcription factors ARX, TCF21, PBX1, MAF, and MAFB expressed in the interstitial steroidogenic progenitors, although their precise roles remain elusive (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Miyabayashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Li et al., 2021</xref>; <xref ref-type="bibr" rid="bib17">Cui et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Schnabel et al., 2003</xref>).</p><p>Nuclear receptor subfamily 2 group F member 2 (NR2F2, also known as COUP-TFII) is abundantly expressed in interstitial progenitors of the fetal and adult testis in rodents and humans (<xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Mendoza-Villarroel et al., 2014b</xref>; <xref ref-type="bibr" rid="bib30">Kilcoyne et al., 2014</xref>; <xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Lottrup et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Qin et al., 2008</xref>; <xref ref-type="bibr" rid="bib69">Taelman et al., 2024</xref>). NR2F2 activates or represses transcription depending on the cellular context by directly binding to DNA responsive elements or by interacting with other transcription factors. NR2F2 regulates cell differentiation during organogenesis, adult tissue homeostasis, and tumorigenesis (<xref ref-type="bibr" rid="bib54">Polvani et al., 2019</xref>). NR2F2 function is essential for cardiac and vascular development so that <italic>Nr2f2</italic> mutation in mouse leads to embryonic lethality at mid-gestation (<xref ref-type="bibr" rid="bib52">Pereira et al., 1999</xref>). The study of mouse conditional mutants has shown that NR2F2 is essential for ALC differentiation in the postnatal testis before puberty (<xref ref-type="bibr" rid="bib55">Qin et al., 2008</xref>). However, the function of NR2F2 in the developing testis during fetal life has not been addressed, and its role in the interstitial progenitors that give rise to the FLC lineage remains unknown. It was initially proposed that NR2F2 could act as a negative regulator of steroidogenesis at fetal stages based on the inverse correlation between NR2F2 expression and steroidogenesis genes and testosterone levels in mouse and rat fetal testes treated with endocrine disruptors (<xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>). More recently, rare variants in NR2F2 have been associated with cryptorchidism, hypospadias, and defective penile growth in human patients (<xref ref-type="bibr" rid="bib80">Zidoune et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Ganapathi et al., 2023</xref>; <xref ref-type="bibr" rid="bib74">Wankanit et al., 2024</xref>). These phenotypes can be attributed to defective testosterone and INSL3 production during gestation (<xref ref-type="bibr" rid="bib25">Hutson et al., 2015</xref>; <xref ref-type="bibr" rid="bib2">Amato et al., 2022</xref>), suggesting a positive role for NR2F2 in promoting FLC differentiation and/or function in the fetal testis.</p><p>In this study, we show that NR2F2 is expressed in interstitial progenitors of coelomic and mesonephric origin of the mouse fetal testes and is downregulated upon FLC differentiation. By using two Cre lines that drive <italic>Nr2f2</italic> deletion in mouse embryonic gonads, we show that NR2F2 is required for fetal mouse testis morphogenesis and for FLC differentiation. Absence of <italic>Nr2f2</italic> does not impair paracrine signals known to regulate FLC differentiation nor the proliferation or survival of the steroidogenic progenitor population. Our findings reveal that NR2F2 promotes the initiation of FLC differentiation as well as FLC maturation. Taken together, these results establish NR2F2 as an essential factor that positively regulates the development of steroidogenic cells in the mouse fetal testis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>NR2F2 is expressed in steroidogenic progenitors of the developing testis</title><p>We analyzed the spatiotemporal distribution of NR2F2 in the developing testis by immunofluorescence. At E11.5 (18–21 tail somites [ts]), NR2F2 was detected in both the coelomic epithelium and the mesonephric mesenchyme adjacent to the gonads, two tissues that contribute to the population of interstitial steroidogenic progenitors (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Karl and Capel, 1998</xref>; <xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="fig" rid="fig1">Figure 1A and C</xref>). The majority of mesenchymal cells in the gonad expressed the transcription factor RUNX1 (RUNX1+) (<xref ref-type="bibr" rid="bib48">Nicol et al., 2019</xref>), indicating that most of the gonadal somatic cells at this stage belong to the supporting lineage (<xref ref-type="fig" rid="fig1">Figure 1A and D</xref>). Nevertheless, NR2F2+ RUNX1- cells were observed, revealing that interstitial progenitors were already present at this stage (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). NR2F2+ cells were either GATA4+ or GATA4-, suggesting that interstitial progenitors of coelomic and mesonephric origins, respectively, were both present (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>NR2F2 is expressed in steroidogenic progenitors of the fetal testis.</title><p>(<bold>A–D</bold>) Immunodetection of NR2F2, RUNX1, and GATA4 on embryonic day 11.5 (E11.5) (18 tail somites) XY gonad. NR2F2 is detected in coelomic epithelium (ce), mesonephros (me), and RUNX1 negative cells that are either GATA4 positive (arrows in A–C) or GATA4 negative (arrowheads in A–C). (<bold>E–H</bold>) Immunodetection of NR2F2 and ARX on E12.5 XY gonad. NR2F2 is co-expressed with ARX in the coelomic epithelium (ce, dotted lines in F–H) and in interstitial cells between the testis cords (arrows in F–H). (<bold>I,J</bold>) Immunodetection of NR2F2 and PDGFRA on E14.5 XY gonad. NR2F2 is detected in PDGFRA positive cells, including interstitial progenitors (arrowheads in J), peritubular myoid cell surrounding testis cords (arrows in J), and cells of the future tunica albuginea (yellow arrow in J). (<bold>K,L</bold>) Immunodetection of NR2F2, NESTIN, and PECAM-1 on E14.5 XY gonad. NR2F2 is detected in NESTIN positive interstitial progenitors, including perivascular cells (arrowheads in L) and peritubular myoid cells (arrow in L). (<bold>M–P</bold>) Immunodetection of NR2F2 and HSD3B on E14.5 XY gonad. NR2F2 is absent from the majority of HSD3B positive fetal Leydig cells (arrowheads in N–P) and is only detected at low levels in a few HSD3B positive elongated cells (arrows in N–P). Data are representative of triplicate biological replicates. Scale bar = 50 µm in A–D, F–H, J, L, and N–P. Scale bar = 100 µm in E, I, K, M.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>NR2F2 is expressed in steroidogenic progenitors of the fetal testis.</title><p>(<bold>A–D</bold>) Immunodetection of NR2F2 and SOX9 on embryonic day 12.5 (E12.5) XY gonad (outlined by dotted lines in A). NR2F2 is detected in interstitial cells outside the testis cords (arrows in B and C). (<bold>E–H</bold>) Immunodetection of NR2F2 and Ki67 on E12.5 XY gonad (outlined by dotted lines in E). NR2F2 positive cells are proliferating (arrows in F–H). (<bold>I–L</bold>) Immunodetection of NR2F2 and HSD3B on E12.5 XY gonad. NR2F2 is detected at low levels in HSD3B positive elongated cells (arrows in J–L). (<bold>M–P</bold>) Immunodetection of NR2F2 and LAMA1 on E14.5 XY gonad. NR2F2 is expressed in peritubular myoid cells lining the basement membrane outside the testis cords (arrow in N–P). Data are representative of triplicate biological replicates. Scale bar = 50 µm in B–D, F–H, J–L, and N–P. Scale bar = 100 µm in A, E, I, M.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig1-figsupp1-v1.tif"/></fig></fig-group><p>In E12.5 testes, NR2F2+ cells were detected in the coelomic epithelium and in the interstitial space outside the developing testis cords (<xref ref-type="fig" rid="fig1">Figure 1E–H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D</xref>). NR2F2+ cells co-expressed the steroidogenic progenitor marker ARX (<xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Miyabayashi et al., 2013</xref>) and were actively proliferating (<xref ref-type="fig" rid="fig1">Figure 1E–H</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–H</xref>). At E14.5, NR2F2 expression was maintained in interstitial cells co-expressing PDGFRA (<xref ref-type="bibr" rid="bib12">Brennan et al., 2003</xref>), as well as in the PTM lining the testis cords and in the cells beneath the surface of the testis that will contribute to the future tunica albuginea (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1M–P</xref>). NR2F2 expression was also found in NESTIN-expressing perivascular cells that correspond to the mesonephros-derived steroidogenic progenitors (<xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="fig" rid="fig1">Figure 1K and L</xref>). In contrast, NR2F2 protein was either absent or detected at very low levels in FLC marked by the expression of the steroidogenic enzyme HSD3B (<xref ref-type="fig" rid="fig1">Figure 1M–P</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I–L</xref>).</p><p>Together, our results show that NR2F2 is expressed in the coelomic epithelium and the mesonephros, as well as in the interstitial progenitors derived from both sources, and is downregulated upon FLC differentiation in the developing testis.</p></sec><sec id="s2-2"><title>NR2F2 is required for fetal testicular morphogenesis and FLC development</title><p>In order to investigate the function of NR2F2 in the developing mouse testis, we used an <italic>Nr2f2<sup>flox</sup></italic> conditional allele (<xref ref-type="bibr" rid="bib25">Hutson et al., 2015</xref>), and a knock-in <italic>Wt1<sup>CreERT2</sup></italic> line, in which tamoxifen-inducible CreERT2 is produced by <italic>Wt1</italic>-expressing cells (<xref ref-type="bibr" rid="bib63">Shima and Morohashi, 2017</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). <italic>Wt1</italic> is expressed from E9.5 in the coelomic epithelium of the gonadal ridge and in the adjacent mesonephros (<xref ref-type="bibr" rid="bib3">Armstrong et al., 1993</xref>), and <italic>Wt1<sup>CreERT2</sup></italic>-mediated recombination can be induced in all somatic gonadal cells upon tamoxifen administration at E9.5 and E10.5 (<xref ref-type="bibr" rid="bib37">Manuylov et al., 2008</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>NR2F2 deletion by <italic>Wt1<sup>CreERT2</sup></italic> impairs Sertoli cell differentiation and fetal Leydig cell (FLC) development.</title><p>(<bold>A</bold>) Generation of <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants. Tamoxifen was administered at embryonic day 9.5 (E9.5) and E10.5, and embryos were recovered at E12.5, E14.5, and E16.5. (<bold>B,C</bold>) Immunodetection of NR2F2 and SOX9 on E12.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines) after tamoxifen treatment at E9.5 and E10.5. NR2F2 is efficiently deleted in the gonad and mesonephros. (<bold>D,E</bold>) Immunodetection of NR2F2 and NESTIN on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes. NR2F2 is efficiently deleted in NESTIN1 positive cells. (<bold>F,G</bold>) Immunodetection of ARX on E12.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines). Interstitial cells are generated in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants. (<bold>H,I</bold>) Macroscopic view of the urogenital tract of XY E16.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes dissected after tamoxifen treatment at E9.5 and E10.5. Testes (<bold>t</bold>) and kidneys (<bold>k</bold>) are hypoplastic in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants. bl: bladder. vd: vas deferens. (<bold>J,K</bold>) Immunodetection of HSD3B on E12.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines). ad: adrenal. (<bold>L,M</bold>) Immunodetection of HSD3B on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes. ad: adrenal. (<bold>N</bold>) Quantification of the number of HSD3B positive cells per surface unit and of the number of SOX9 positive cells per surface unit in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes. Each triangle represents the mean number of HSD3B or SOX9 positive cells per surface unit of one individual measured on at least two sections per gonad. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>O</bold>) Quantification of <italic>Cyp11a1</italic>, <italic>Cyp17a1, Insl3,</italic> and <italic>Sox9</italic> transcripts in <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes treated with tamoxifen at E9.5 and E10.5 and dissected at E14.5 after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. Immunodetection data are representative of triplicate biological replicates. Scale bar = 100 µm in B–G, J–M. Scale bar = 500 µm in H, I.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for cell counts and RT-qPCR data in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>NR2F2 deletion by <italic>Wt1<sup>CreERT2</sup></italic> impairs Sertoli cell differentiation and fetal Leydig cell (FLC) development.</title><p>(<bold>A</bold>) Immunodetection of NR2F2 and GFP on embryonic day 14.5 (E14.5) XY <italic>Wt1<sup>CreERT2</sup>;mT/mG</italic> gonad after tamoxifen was administered at E9.5 and E10.5. Upon Cre-mediated recombination, GFP is expressed in all somatic cells of the gonad, including NR2F2 positive cells (arrows). (<bold>B</bold>) Quantification of <italic>Nr2f2</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR in <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes dissected at E12.5 and E14.5 after tamoxifen treatment at E9.5 and E10.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>C–F</bold>) Immunodetection of NR2F2 and WT1 on E11.5 XY gonad. NR2F2 is co-expressed with WT1 in the coelomic epithelium (ce), in the mesonephros (me), and in interstitial steroidogenic progenitors (arrows). (<bold>G,H</bold>) Immunodetection of ACTA2 on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes. The expression in the future tunica albuginea (arrow in G) is impaired in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants. (<bold>I,J</bold>) Immunodetection of WT1 and COL4A1 on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes. Testis cords are enlarged and abnormally shaped in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants. (<bold>K</bold>) Quantification of <italic>Dhh</italic>, <italic>Pdgfa,</italic> and <italic>Amh</italic> transcripts in <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes treated with tamoxifen at E9.5 and E10.5 and dissected at E14.5 after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>L</bold>) Quantification of <italic>Cyp11a1, Cyp17a1, Dhh, Pdgfa,</italic> and <italic>Amh</italic> transcripts in <italic>Nr2f2<sup>+/+</sup></italic> and <italic>Wt1<sup>CreERT2/+</sup></italic> testes treated with tamoxifen at E9.5 and E10.5 and dissected at E14.5 after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>M</bold>) Quantification of the testis cord area in control testes (n=60 testis cords from 2 <italic>Nr2f2</italic>1 and 1 <italic>Nr2f2<sup>flox/+</sup></italic> embryos, average testis cord number per embryo = 21) and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes (n=26 testis cords from 3 embryos, average testis cord number per embryo = 9) dissected at E14 after tamoxifen treatment at E9.5 and E10.5. Testis cords were identified on sections by immunodetection with anti-SOX9 antibodies. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05. Immunodetection data are representative of triplicate biological replicates. Scale bar = 50 µm in D–F. Scale bar = 100 µm in A, C, G–J.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for testis cord measurements and RT-qPCR data in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig2-figsupp1-v1.tif"/></fig></fig-group><p>NR2F2 is co-expressed with WT1 in the gonadal coelomic epithelium, in the mesonephros, and in interstitial cells (<xref ref-type="bibr" rid="bib78">Yu et al., 2012</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–F</xref>). Tamoxifen treatment at E9.5 and E10.5 triggered an efficient NR2F2 deletion in gonadal and mesonephric tissues of <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> embryos analyzed at E12.5 and E14.5 (<xref ref-type="fig" rid="fig2">Figure 2A–E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). NR2F2 expression was completely absent in gonadal interstitial cells, including NESTIN+ cells, demonstrating that all interstitial steroidogenic progenitors were targeted in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> embryos (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Morphological examination of the urogenital system of E16.5 <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> embryos revealed hypoplastic undescended testes, as well as hypoplastic kidneys (<xref ref-type="fig" rid="fig2">Figure 2H and I</xref>), indicating that NR2F2 function is required for testicular and kidney development.</p><p>Sertoli cells expressing SOX9 (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>) and interstitial progenitors marked by ARX (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>) were present in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> embryos at E12.5. However, differentiated steroidogenic FLC (marked by HSD3B expression) were almost completely absent in the mutant gonads (<xref ref-type="fig" rid="fig2">Figure 2J, K, and N</xref>). This phenotype was not due to a delay in the initiation of FLC differentiation, as the number of HSD3B positive cells remained strongly reduced in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutant gonads at E14.5 (60% reduction, <xref ref-type="fig" rid="fig2">Figure 2L–N</xref>). In addition, the transcripts of <italic>Cyp11a1</italic> and <italic>Cyp17a1</italic>, two genes encoding steroidogenic enzymes expressed in FLC, and of <italic>Insl3</italic> were strongly reduced (<xref ref-type="fig" rid="fig2">Figure 2O</xref>), providing a possible explanation for the observed undescended testes phenotype (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G and H</xref>). The mutant gonads showed fewer testis cords that were enlarged and exhibited irregular shapes at E14.5 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1J and M</xref>). Moreover, the expression of ACTA2 was strongly reduced both in the periphery of the gonad and in cells lining the testis cords, indicating that tunica cell and PTM development were impaired in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G and H</xref>). Together, these results demonstrate that NR2F2 function is not essential for the initial specification of the interstitial and supporting cells of the testis but is required for testicular morphogenesis and for FLC development.</p></sec><sec id="s2-3"><title>Sertoli cell development is impaired in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes</title><p>FLC differentiation relies on signals produced by Sertoli cells such as DHH and PDGFA acting on interstitial cells (<xref ref-type="bibr" rid="bib57">Rotgers et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Wen et al., 2016</xref>). The number of Sertoli cells expressing SOX9 and the levels of <italic>Sox9</italic> transcripts were not altered in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants at E14.5 (<xref ref-type="fig" rid="fig2">Figure 2N and O</xref>). However, the expression of <italic>Dhh, Pdgfa,</italic> and <italic>Amh</italic>, another marker of differentiated Sertoli cells, was reduced in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants compared to <italic>Nr2f2<sup>flox/+</sup></italic> control gonads (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1K</xref>), indicating that Sertoli cell differentiation is abnormal in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> gonads. WT1 is required for Sertoli cell development (<xref ref-type="bibr" rid="bib23">Gao et al., 2006</xref>), and previous work suggested that <italic>Wt1</italic> heterozygosity in <italic>Wt1<sup>CreERT2</sup></italic><sup>/+</sup> gonads results in delayed testicular development (<xref ref-type="bibr" rid="bib14">Carré et al., 2018</xref>). To discriminate between the effects of <italic>Nr2f2</italic> loss of function and <italic>Wt1</italic> heterozygosity in the phenotype of <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants, we analyzed gene expression in <italic>Wt1<sup>CreERT2/+</sup></italic> testes compared to wild-type littermates. We found that the expression of the FLC markers <italic>Cyp11a1</italic> and <italic>Cyp17a1</italic> was not significantly different in <italic>Wt1<sup>CreERT2/+</sup></italic> testes compared to wild-type littermates (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1L</xref>). In contrast, transcript levels of <italic>Dhh, Pdgfa,</italic> and <italic>Amh</italic> were significantly reduced (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1L</xref>). While these results indicate that impaired FLC development in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants is associated with the loss of <italic>Nr2f2</italic> function, the potential contribution of Sertoli cell defects caused by <italic>Wt1</italic> heterozygosity to the FLC phenotype cannot be ruled out in this model.</p></sec><sec id="s2-4"><title>NR2F2 is required in the steroidogenic lineage for FLC development</title><p>In order to elucidate the specific function of NR2F2 in the steroidogenic lineage for FLC development, we used the transgenic <italic>Nr5a1-Cre</italic> line which drives robust recombination in somatic gonadal cells from E11.5, after the supporting and steroidogenic lineages have been specified (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>; <xref ref-type="bibr" rid="bib11">Bingham et al., 2006</xref>; <xref ref-type="bibr" rid="bib38">Manuylov et al., 2011</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>NR2F2 deletion by Nr5a1-Cre impairs fetal Leydig cell (FLC) development.</title><p>(<bold>A</bold>) Generation of <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants. (<bold>B,C</bold>) Immunodetection of NR2F2 and SOX9 on embryonic day 12.5 (E12.5) <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines). NR2F2 is deleted in interstitial cells but is still present in the outermost layer of the testis. (<bold>D,E</bold>) Immunodetection of NR2F2 and NESTIN on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. NR2F2 is still detected in NESTIN1 positive cells. (<bold>F,G</bold>) Immunodetection of ARX on E12.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines). Interstitial cells are generated in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants. (<bold>H</bold>) Quantification of <italic>Sox9, Dhh, Pdgfa,</italic> and <italic>Amh</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> by RT-qPCR at E14.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>I,J</bold>) Immunodetection of HSD3B on E12.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes (outlined by dotted lines). ad: adrenal. (<bold>K,L</bold>) Immunodetection of HSD3B on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>M</bold>) Quantification of the number of HSD3B positive cells per surface unit in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes at E12.5 and E14.5. Each circle represents the mean number of HSD3B positive cells per surface unit of one individual measured on at least two sections per gonad. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>N</bold>) Quantification of <italic>Cyp11a1</italic>, <italic>Cyp17a1,</italic> and <italic>Insl3</italic> after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> by RT-qPCR at E14.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>O,P</bold>) Macroscopic view of the urogenital tract of XY P3 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants. The testes are in abdominal position in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants. k: kidney, t: testis, bl: bladder. vd: vas deferens. Immunodetection data are representative of triplicate biological replicates. Scale bar = 100 µm in B–G, I–L. Scale bar = 500 µm in O, P.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for cell counts and RT-qPCR data in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>NR2F2 deletion by Nr5a1-Cre impairs fetal Leydig cell (FLC) development.</title><p>(<bold>A,B</bold>) Immunodetection of NR2F2 and GFP on embryonic day 14.5 (E14.5) XY <italic>Nr5a1-Cre;mT/mG</italic> gonad. Upon Cre-mediated recombination, GFP is expressed in somatic cells of the gonad including NR2F2 positive cells (arrows); however, the outermost layer and some interstitial NR2F2 positive cells (arrowheads) do not express GFP. (<bold>C</bold>) Quantification of <italic>Nr2f2</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes dissected at E12.5 and E14.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05. (<bold>D–G</bold>) Immunodetection of NR2F2 and NR5A1 on E11.5 XY gonad. NR2F2 is co-expressed with NR5A1 in the coelomic epithelium (ce) and in interstitial steroidogenic progenitors (arrows). NR2F2 positive cells that do not express NR5A1 are likely steroidogenic progenitors of mesonephric (me) origin (arrowheads). (<bold>H,I</bold>) Immunodetection of NESTIN on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Images corresponding to the samples shown in <xref ref-type="fig" rid="fig3">Figure 3D and E</xref>. (<bold>J,K</bold>) Immunodetection of ACTA2 on E14.5 <italic>Nr2f2<sup>flox/flox</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. White arrows indicate cells that will form the tunica albuginea. (<bold>L,M</bold>) Immunodetection of CYP11A1 (arrows) on E14.5 <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>N</bold>) Quantification of <italic>Sox9, Dhh, Gli1,</italic> and <italic>Amh</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes at E12.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. ns indicates p-value&gt;0.05. (<bold>O</bold>) Quantification of the number of SOX9 positive cells per surface unit in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes at E14.5. Each circle represents the mean number of SOX9 positive cells per surface unit of one individual measured on at least two sections per gonad. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. ns indicates p-value&gt;0.05. (<bold>P</bold>) Anogenital distance (distance between the anus and the external genitalia measured with an electronic caliper) in control females (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>, inverted triangles), control males (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>, black circles), and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> males (red circles) measured at P0 (solid symbols) and P1 (open symbols). Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05. Immunodetection data are representative of triplicate biological replicates. Scale bar = 50 µm in B, E–G. Scale bar = 100 µm in A, D, H–M.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data for cell counts, anogenital distance measurments and RT-qPCR data in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig3-figsupp1-v1.tif"/></fig></fig-group><p>At E11.5, NR5A1 is co-expressed with NR2F2 in the gonadal coelomic epithelium and in interstitial cells, but is absent from the mesonephros and mesonephros-derived cells (<xref ref-type="bibr" rid="bib66">Stévant et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D–G</xref>). <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants show efficient <italic>Nr2f2</italic> deletion in gonadal interstitial cells at E12.5 and E14.5 (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Consistent with previous reports on the activity of <italic>Nr5a1-Cre</italic> (<xref ref-type="bibr" rid="bib38">Manuylov et al., 2011</xref>), NR2F2 was still detected in the coelomic epithelium layer and in interstitial cells just beneath it, particularly in the anterior part of the gonad of <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>). NESTIN+ NR2F2+ cells were still present, confirming that steroidogenic progenitors of mesonephric origin were not targeted by <italic>Nr5a1-Cre</italic> (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref><italic>,</italic> <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H and I</xref>; <xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>). Together, these results demonstrate that in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants, NR2F2 is deleted after E11.5 in interstitial cells derived from the coelomic epithelium, except in the outermost layer of the testis.</p><p><italic>Nr2f2</italic> deletion by <italic>Nr5a1-Cre</italic> did not affect the initial formation of the supporting and steroidogenic lineages as evidenced by SOX9 (<xref ref-type="fig" rid="fig3">Figure 3B, C, and H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1N and O</xref>) and ARX expression (<xref ref-type="fig" rid="fig3">Figure 3F and G</xref>), nor the differentiation of Sertoli cells as shown by normal expression levels of <italic>Dhh, Pdgfa,</italic> and <italic>Amh</italic> (<xref ref-type="fig" rid="fig3">Figure 3H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1N</xref>). In addition, ACTA2 was detected in PTM and was only slightly reduced in the tunica albuginea of the posterior region in the mutant testes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J and K</xref>). In contrast, the FLC population marked by HSD3B or CYP11A1 was decreased (40% reduction, <xref ref-type="fig" rid="fig3">Figure 3I–M</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L and M</xref>), and the expression of the FLC markers <italic>Cyp11a1</italic>, <italic>Cyp17a1,</italic> and <italic>Insl3</italic> was strongly downregulated in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutant testes (<xref ref-type="fig" rid="fig3">Figure 3N</xref>). We conclude that <italic>Nr2f2</italic> deletion after E11.5 by <italic>Nr5a1-Cre</italic> leads to FLC reduction without Sertoli cell defects, suggesting that NR2F2 is required cell-autonomously in the interstitial cells for FLC development.</p><p>In agreement with reduced <italic>Insl3</italic> expression, the testes of <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> embryos were undescended and exhibited an abnormal abdominal position at postnatal day (P) 3 (<xref ref-type="fig" rid="fig3">Figure 3O and P</xref>). In addition, the anogenital distance, a readout for androgen levels (<xref ref-type="bibr" rid="bib61">Schwartz et al., 2019</xref>), was reduced in P0 and P1 <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> males when compared to male controls (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1P</xref>), consistent with the reduced expression of steroidogenic enzymes in the mutant testes. We conclude that defective FLC development in <italic>Nr2f2</italic> mutants results in cryptorchidism and impaired masculinization of the external genitalia.</p></sec><sec id="s2-5"><title>NR2F2 is required for the initiation of FLC differentiation</title><p>FLCs differentiate from proliferating interstitial progenitors that progressively lose their mitotic ability, downregulate the transcription factors ARX and NR2F2, upregulate the master regulator of steroidogenesis NR5A1, and activate the expression of steroidogenesis-related genes (<xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Miyabayashi et al., 2013</xref>). We wanted to determine which of these steps of FLC differentiation are NR2F2 dependent.</p><p>The transcription factor ARX is required in the pool of proliferating interstitial progenitors for FLC development (<xref ref-type="bibr" rid="bib44">Miyabayashi et al., 2013</xref>). We first examined whether NR2F2 regulates the survival, proliferation, or identity of the ARX+ cell population. We found that the expression of <italic>Arx</italic> mRNA was not modified in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). The total number of gonadal cells, the percentage of ARX+ cells among the total number of gonadal cells, and the fraction of proliferating cells among the ARX+ population were similar to controls at E12.5 and E14.5 (<xref ref-type="fig" rid="fig4">Figure 4A, B, and E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–E</xref>). In addition, we did not find evidence of increased cell death in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F–H</xref>). Together, these results indicate that ARX+ steroidogenic progenitor cells are present and proliferate at normal rates in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>NR2F2 function is required for the initiation of fetal Leydig cell (FLC) differentiation.</title><p>(<bold>A,B</bold>) Immunodetection of ARX and BrdU (arrows) on embryonic day 14.5 (E14.5) XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>C,D</bold>) Immunodetection of NR5A1 on E14.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Arrows indicate strong expression of NR5A1 positive FLC. (<bold>E</bold>) Quantification of the percentage of ARX positive cells (number of ARX positive nuclei relative to the total number of nuclei labeled by DAPI), of the percentage of ARX positive cells labeled by BrdU (number of nuclei positive for ARX and BrdU relative to the number of ARX positive nuclei) and of the number of NR5A1 positive cells per surface unit in E14.5 XY control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Each circle represents the mean percentage of ARX+ or ARX+/BrdU+ or NR5A1+ cells per surface unit of one individual measured on at least two sections per gonad. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>F</bold>) Quantification of <italic>Gli1</italic>, <italic>Pdgfra</italic>, <italic>Pdgfb,</italic> and <italic>Sgpl1</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> by RT-qPCR at E14.5. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>G,H</bold>) In situ hybridization detection of <italic>Gli1</italic> transcripts and immunodetection of HSD3B protein on E14.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>I,J</bold>) Immunodetection of PDGFRA on E14.5 XY <italic>Nr2f2<sup>flox/flox</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>K,L</bold>) Immunodetection of PECAM-1 and NR2F2 on E12.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. PECAM-1 is expressed in germ cells and in endothelial cells (white arrows). (<bold>M</bold>) Quantification of Cdh5, <italic>Notch2, Heyl, and Hes1</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> by RT-qPCR at E14.5. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. Immunodetection data are representative of triplicate biological replicates. Scale bar = 100 µm.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for cell counts and RT-qPCR data in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>NR2F2 function is required for the initiation of fetal Leydig cell (FLC) differentiation.</title><p>(<bold>A</bold>) Quantification of <italic>Arx</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR at embryonic day 14.5 (E14.5) and E12.5. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>B</bold>) Quantification of the total number of gonadal cells labeled by DAPI per gonadal section on E14.5 and E12.5 XY control (wild-type or <italic>Nr2f2<sup>flox/+</sup>),</italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Each circle represents the mean percentage of gonadal cells of one individual measured on at least two sections per gonad. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>C,D</bold>) Immunodetection of ARX and BrdU (arrows) on E12.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>E</bold>) Quantification of the percentage of ARX positive cells (number of ARX positive nuclei relative to the total number of nuclei labeled by DAPI) and of the percentage of ARX positive cells labeled by BrdU (number of nuclei positive for ARX and BrdU relative to the number of ARX positive nuclei) on E12.5 XY control (wild-type or <italic>Nr2f2<sup>flox/+</sup>)</italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Each circle represents the mean percentage of ARX+ or ARX+/BrdU+ cells per surface unit of one individual measured on at least two sections per gonad. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>F,G</bold>) Immunodetection of activated caspase 3 (arrow in F) and AMH on E14.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>H</bold>) Quantification of the number of caspase 3 positive cells per 100,000 µm<sup>2</sup> of interstitial area (area outside the testis cords) on E14.5 XY control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. Each circle represents the mean number of activated caspase 3 positive cells per surface unit of one individual measured on at least two sections per gonad. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. ns indicates p-value&gt;0.05. (<bold>I,J</bold>) Immunodetection of NR5A1 on E12.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. ad: adrenal. Immunodetection data are representative of triplicate biological replicates. Scale bar = 100 µm.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for cell counts and RT-qPCR data in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig4-figsupp1-v1.tif"/></fig></fig-group><p>As the ARX+ steroidogenic progenitors adopt an FLC identity, NR2F2 is progressively lost, and the nuclear receptor NR5A1 is strongly upregulated (<xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>). NR5A1 directs FLC differentiation by regulating the expression of genes associated with cholesterol metabolism and steroidogenesis (<xref ref-type="bibr" rid="bib46">Morohashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Shima et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Jeyasuria et al., 2004</xref>; <xref ref-type="bibr" rid="bib13">Buaas et al., 2012</xref>). In <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants, the cells expressing high levels of NR5A1+ in the interstitial compartment were reduced compared to controls (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref><italic>,</italic> <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I and J</xref>). This observation indicates that NR2F2 function is required for NR5A1 upregulation at the initial step of steroidogenic cell differentiation.</p></sec><sec id="s2-6"><title>DHH, PDGFRA, and NOTCH pathways are not impaired in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants</title><p>We next investigated the impact of <italic>Nr5a1-Cre; Nr2f2 <sup>flox/flox</sup></italic> mutation on the activation of the signaling pathways involved in FLC differentiation. DHH secreted by Sertoli cells binds to its receptor PTCH1 expressed in interstitial progenitors and activates its target genes, including <italic>Gli1,</italic> to promote FLC differentiation (<xref ref-type="bibr" rid="bib76">Yao et al., 2002</xref>; <xref ref-type="bibr" rid="bib8">Barsoum and Yao, 2011</xref>). The expression levels of <italic>Dhh</italic> and of its target <italic>Gli1</italic>, a readout of Hedgehog pathway activation, were not modified in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig3">Figure 3H</xref><italic>,</italic> <xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1N</xref>). <italic>Gli1</italic> transcripts exhibited a similar distribution in interstitial cells of control and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants at E14.5 (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). PDGFA produced by Sertoli cells binds to the PDGFRA receptor expressed in interstitial progenitors to activate downstream signaling required for FLC development (<xref ref-type="bibr" rid="bib12">Brennan et al., 2003</xref>; <xref ref-type="bibr" rid="bib59">Schmahl et al., 2008</xref>). The expression levels of <italic>Pdgfa</italic> and <italic>Pdgfb</italic>, coding for two PDGFRA ligands expressed in developing testes (<xref ref-type="bibr" rid="bib12">Brennan et al., 2003</xref>), were not altered in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig3">Figures 3H</xref> and <xref ref-type="fig" rid="fig4">4F</xref>). Transcript levels of <italic>Pdgfra</italic> were unchanged in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4F</xref>), and PDGFRA protein was detected at the plasma membrane of interstitial cells in both control and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutant testes at E14.5 (<xref ref-type="fig" rid="fig4">Figure 4I and J</xref>). In addition, the expression of <italic>Sgpl1</italic>, a PDGFRA signaling target involved in steroidogenic differentiation (<xref ref-type="bibr" rid="bib59">Schmahl et al., 2008</xref>), was not reduced in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). These observations indicate that the activities of Hedgehog and PDGFRA signaling, two pathways that positively regulate FLC differentiation, are not impaired in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants.</p><p>In addition to the positive signals, FLC differentiation is also negatively modulated by NOTCH signaling triggered by ligands expressed in vascular and perivascular cells. An increase in testicular endothelial cells results in a reduction in FLC numbers (<xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="bibr" rid="bib70">Tang et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Defalco et al., 2013</xref>). The distribution and abundance of endothelial cells marked by PECAM-1 was not altered in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4K and L</xref>). In addition, <italic>Cdh5</italic> transcript levels (a readout of the abundance of endothelial cells) were similar in controls and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4M</xref>). These observations indicate that the reduction in FLCs in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants was not associated with an increased population of endothelial cells. The receptor NOTCH2 expressed in interstitial cells is involved in restricting FLC differentiation (<xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>; <xref ref-type="bibr" rid="bib70">Tang et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Defalco et al., 2013</xref>). <italic>Notch2</italic> mRNA levels were not altered in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4M</xref>). NOTCH signaling activates the expression of its target genes (that also act as effectors of the pathway), including <italic>Heyl</italic>, specifically expressed in interstitial cells and strongly upregulated upon vascular depletion (<xref ref-type="bibr" rid="bib32">Kumar and DeFalco, 2018</xref>) and <italic>Hes1,</italic> expressed in interstitial cells and involved in restricting FLC differentiation (<xref ref-type="bibr" rid="bib70">Tang et al., 2008</xref>; <xref ref-type="bibr" rid="bib35">Liu et al., 2016</xref>). Transcripts of the NOTCH pathway targets <italic>Hes1</italic> and <italic>Heyl</italic> were detected at similar levels in controls and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutants (<xref ref-type="fig" rid="fig4">Figure 4M</xref>), indicating that the observed decrease in FLC numbers cannot be attributed to an increase in NOTCH signaling.</p><p>Together, these results indicate that NR2F2 deficiency does not impact the activity of the signaling pathways known to induce or repress FLC formation, suggesting that NR2F2 acts downstream or in parallel to these pathways to regulate FLC differentiation from interstitial progenitors.</p></sec><sec id="s2-7"><title>NR2F2 is required for FLC maturation</title><p>A small fraction of HSD3B positive cells formed in the absence of NR2F2 function, even in the case of <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutant gonads that exhibit widespread NR2F2 deletion in steroidogenic progenitors of coelomic and mesonephric origin. One possibility is that these cells are ALCs that have prematurely differentiated in <italic>Nr2f2</italic> mutant fetal testes. <italic>Bhmt</italic> (<italic>Betaine-homocysteine methyltransferase</italic>) is specifically expressed in ALC and absent in FLC (<xref ref-type="bibr" rid="bib58">Sararols et al., 2021</xref>). <italic>Bhmt</italic> transcripts were not detected in control or <italic>Nr2f2</italic> mutant testes by RT-qPCR at E14.5, while they were present in adult testes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), indicating that the steroidogenic cells of the mutants do not have adult characteristics.</p><p>To evaluate the steroidogenic capacities of the remaining FLC in <italic>Nr2f2</italic> mutant gonads, we analyzed the transcript levels of <italic>Cyp11a1</italic> and <italic>Cyp17a1</italic> normalized to the FLC number as quantified by HSD3B immunofluorescence (<xref ref-type="fig" rid="fig2">Figure 2N</xref><italic>,</italic> <xref ref-type="fig" rid="fig3">Figure 3M</xref>; <xref ref-type="bibr" rid="bib31">Kothandapani et al., 2020</xref>). Normalized data showed reduced steroidogenic gene expression in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> and in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutant testes (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>), in agreement with the reduced HSD3B expression levels detected by immunofluorescence in <italic>Nr2f2</italic> mutant testes (<xref ref-type="fig" rid="fig2">Figures 2J–M</xref>–<xref ref-type="fig" rid="fig3">3I–L</xref>). These observations suggest that FLC formed in the mutant testes have reduced steroidogenic function.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>NR2F2 function is required for fetal Leydig cell (FLC) maturation.</title><p>(<bold>A</bold>) RT-qPCR quantification of <italic>Cyp11a1</italic> and <italic>Cyp17a1</italic> transcripts in control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>) and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> and to the number of FLC as quantified by HSD3B immunofluorescence at embryonic day 14.5 (E14.5). Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>B</bold>) RT-qPCR quantification of <italic>Cyp11a1</italic> and <italic>Cyp17a1</italic> transcripts in <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> gonads after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> and to the number of FLC as quantified by HSD3B immunofluorescence at E14.5. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>C,D</bold>) Immunodetection of HSD3B on E14.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes. (<bold>E,F</bold>) Immunodetection of HSD3B on E14.5 XY <italic>Nr2f2<sup>flox/+</sup></italic> and <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> testes after tamoxifen was administered at E9.5 and E10.5. (<bold>G</bold>) Quantification of the area and circularity of HSD3B positive cells in two E14.5 control (wild-type or <italic>Nr2f2<sup>flox/+</sup>,</italic> 737 cells, gray violin plot) and three <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> (486 cells, red violin plot) testes. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>H</bold>) Quantification of the area and circularity of HSD3B positive cells in three E14.5 control (wild-type or <italic>Nr2f2<sup>flox/+</sup>,</italic> 1485 cells, gray violin plot) and three <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> (474 cells, blue violin plot) testes. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05. (<bold>I</bold>) Summary figure: NR2F2 is expressed in spindle-shaped interstitial steroidogenic progenitors together with ARX and is progressively downregulated upon FLC differentiation. NR2F2 is required for the initiation of FLC differentiation (marked by the upregulation of NR5A1) and for FLC maturation (characterized by the increase in cytoplasmic volume and the high expression of steroidogenic enzymes and <italic>Insl3</italic>). Immunodetection data are representative of triplicate biological replicates. Scale bar = 10 µm.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for cell measurements and RT-qPCR data in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>NR2F2 function is required for fetal Leydig cell (FLC) maturation.</title><p>(<bold>A</bold>) Quantification of <italic>Bhmt</italic> transcripts after normalization to <italic>Sdha</italic> and <italic>Tbp</italic> by RT-qPCR at embryonic day 14.5 (E14.5) in XY control (wild-type or <italic>Nr2f2<sup>flox/+</sup></italic>), and <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> testes and in wild-type adult testes. (<bold>B</bold>) Quantification of the circularity and area of HSD3B positive cells in two E14.5 control (wild-type or <italic>Nr2f2<sup>flox/+</sup>,</italic> 737 cells, black open circles) and three <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> (486 cells, red open triangles) testes. (<bold>C</bold>) Quantification of the circularity and area of HSD3B positive cells in three E14.5 control (wild-type or <italic>Nr2f2<sup>flox/+</sup>,</italic> 1485 cells, black open circles) and three <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> (474 cells, blue open triangles) testes.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for RT-qPCR data in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-103783-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-103783-fig5-figsupp1-v1.tif"/></fig></fig-group><p>FLC differentiation is accompanied by a change in cell shape from spindle-shaped progenitors to round-shaped FLC and an increase in cytoplasmic volume (<xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haider, 2004</xref>). HSD3B positive FLC present in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> and in <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> mutants were smaller and more elongated than those in control littermates (<xref ref-type="fig" rid="fig5">Figure 5C–H</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). These cellular characteristics have been associated with immature FLC at the initial stages of FLC differentiation before the formation of large and round testosterone-producing FLC (<xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haider, 2004</xref>).</p><p>Taken together, our results show that NR2F2 is required in interstitial steroidogenic progenitor cells for initiation of FLC differentiation but also for the subsequent step of FLC maturation leading to robust steroid production (<xref ref-type="fig" rid="fig5">Figure 5I</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>NR2F2 protein is expressed in interstitial cells of coelomic epithelium and mesonephric origin and is absent or detected at very low levels in FLC as soon as they are formed at E12.5. Our observations are consistent with NR2F2 positive cells being progenitors for FLC (<xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib21">Estermann et al., 2025</xref>) and indicate that NR2F2 is quickly downregulated upon differentiation of the fetal steroidogenic lineage, when the cells begin to synthesize steroid hormones.</p><p>We used two Cre lines to address the role of NR2F2 in the mouse fetal testis. <italic>Nr2f2</italic> mutants exhibit reduced FLC numbers together with a strong reduction in <italic>Insl3</italic> and steroidogenic gene expression, resulting in cryptorchidism and reduced anogenital distance. Importantly, the reduction of <italic>Insl3</italic> expression is sufficient to impair testis descent even when a fraction of FLC is still present. Our findings identify NR2F2 as an essential regulator of FLC and male reproductive system development in the mouse. This conclusion is confirmed by an independent <italic>Nr2f2</italic> conditional mutation resulting in a similar phenotype of FLC hypoplasia, cryptorchidism, and hypospadias (<xref ref-type="bibr" rid="bib21">Estermann et al., 2025</xref>).</p><p><italic>Nr2f2</italic> deletion using <italic>Nr5a1-Cre</italic> does not impair the survival or proliferation of the interstitial steroidogenic progenitor population, yet the FLC population is reduced in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutant testes. We found that the expression of the master regulator of steroidogenic differentiation of NR5A1 is not upregulated in <italic>Nr2f2</italic> mutants, which is sufficient to account for the decrease in FLC numbers (<xref ref-type="bibr" rid="bib46">Morohashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Baba et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Baba et al., 2014</xref>; <xref ref-type="bibr" rid="bib64">Shima et al., 2018</xref>). ChIP-seq analysis of whole E14.5 testes has identified NR2F2 binding peaks in the regulatory region of <italic>Nr5a1</italic> (<xref ref-type="bibr" rid="bib21">Estermann et al., 2025</xref>). In addition, NR2F2 regulates gene expression by directly interacting with NR5A1 in MA-10 cells, an in vitro model for immature ALCs (<xref ref-type="bibr" rid="bib43">Mendoza-Villarroel et al., 2014b</xref>; <xref ref-type="bibr" rid="bib42">Mendoza-Villarroel et al., 2014a</xref>; <xref ref-type="bibr" rid="bib20">Di-Luoffo et al., 2022</xref>). It would be interesting to explore whether an interaction between NR2F2 and NR5A1 contributes to the strong upregulation of <italic>Nr5a1</italic> itself in differentiating FLCs and/or whether NR2F2 cooperates with other factors for the regulation of <italic>Nr5a1</italic>.</p><p>The activity of the main paracrine pathways regulating FLC differentiation was not significantly altered in <italic>Nr5a1-Cre; Nr2f2<sup>flox/flox</sup></italic> mutant testes, as shown by the expression of target genes of the DHH, PDGFRA, and NOTCH signaling. These observations indicate that NR2F2 is a permissive factor in steroidogenic progenitors acting downstream or in cooperation with the signaling pathways regulating FLC differentiation. NR2F2 expression has been found to be modulated by Hedgehog and/or NOTCH signaling in other cell types, and whether a similar regulation of <italic>Nr2f2</italic> expression by DHH and NOTCH signaling occurs in the steroidogenic progenitors remains unknown (<xref ref-type="bibr" rid="bib33">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib68">Swift et al., 2014</xref>).</p><p>A fraction of FLC differentiates in <italic>Nr2f2</italic> mutants, including when progenitors of both coelomic epithelium and mesonephric origins are targeted. This observation indicates that additional factors cooperate with NR2F2 to regulate the transition from the steroidogenic progenitor state to the differentiating FLC. The homeodomain protein ARX is expressed in <italic>Nr2f2</italic> mutant steroidogenic progenitors and is a good candidate to be such a factor. <italic>Arx</italic> mutants exhibit decreased FLC numbers without defects in paracrine signals driving their differentiation, similar to <italic>Nr2f2</italic> mutants (<xref ref-type="bibr" rid="bib44">Miyabayashi et al., 2013</xref>).</p><p>FLC and ALC are morphologically, transcriptionally, and functionally distinct (<xref ref-type="bibr" rid="bib65">Shima, 2019</xref>; <xref ref-type="bibr" rid="bib58">Sararols et al., 2021</xref>), yet NR2F2 function is required for the differentiation of both lineages. In contrast to the situation in the fetal testis, NR2F2 is maintained in cells that have started to express steroidogenesis genes in the postnatal testis (<xref ref-type="bibr" rid="bib26">Inoue et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Ademi et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Mendoza-Villarroel et al., 2014b</xref>). NR2F2 regulates the transition from the adult progenitor Leydig cell (characterized by their elongated shape, their ability to proliferate, and a low level of testosterone synthesis) to the immature ALC (characterized by their round shape, low mitotic activity, and increased testosterone production) (<xref ref-type="bibr" rid="bib55">Qin et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Haider, 2004</xref>). In agreement with its in vivo role promoting maturation along the ALC lineage, NR2F2 cooperates with NR5A1 and GATA4 to activate the transcription of <italic>Insl3</italic>, <italic>Star</italic> (encoding the cholesterol transporter), and <italic>Amhr2</italic> (<xref ref-type="bibr" rid="bib43">Mendoza-Villarroel et al., 2014b</xref>; <xref ref-type="bibr" rid="bib42">Mendoza-Villarroel et al., 2014a</xref>; <xref ref-type="bibr" rid="bib20">Di-Luoffo et al., 2022</xref>; <xref ref-type="bibr" rid="bib40">Mehanovic et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Mehanovic et al., 2022</xref>) in MA-10 cells.</p><p>Here, we found that the steroidogenic cells that differentiate in <italic>Nr2f2</italic> mutant fetal testes exhibit a small size, an elongated shape, and reduced steroidogenic gene expression, features of the earliest stages of FLC differentiation (<xref ref-type="bibr" rid="bib75">Wen et al., 2016</xref>; <xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Haider, 2004</xref>). A similar phenotype is obtained when <italic>Nr5a1</italic> is deleted after the onset of FLC differentiation (<xref ref-type="bibr" rid="bib13">Buaas et al., 2012</xref>). This suggests that in addition to controlling the initial engagement of steroidogenic progenitors into the FLC lineage and similar to the situation in the postnatal testis, NR2F2 promotes FLC maturation possibly by directly regulating the initial expression of genes involved in steroidogenesis. In agreement with this hypothesis, NR2F2 binding peaks are found in the regulatory regions of genes involved in lipid metabolism and cholesterol biosynthesis in ChIP-seq analysis of whole E14.5 testes (<xref ref-type="bibr" rid="bib21">Estermann et al., 2025</xref>).</p><p>NR2F2 is required for additional aspects of fetal testis morphogenesis and differentiation. Testis cords are enlarged and abnormally shaped in <italic>Nr2f2</italic> mutants. Testis cord development involves the formation of Sertoli-germ cell masses after E11.5 and their subsequent partition by growing wedges of interstitial cells and associated vascular branches at E12.5 (<xref ref-type="bibr" rid="bib16">Cool et al., 2012</xref>). How NR2F2-dependent regulation of interstitial cell adhesion or migration contributes to this process will be the aim of future research.</p><p>Pathogenic variants in NR2F2 have been associated with congenital malformations, including congenital heart disease, congenital diaphragmatic hernia, and syndromic 46,XX testicular or ovo-testicular difference/disorder in sex development (DSD) (<xref ref-type="bibr" rid="bib54">Polvani et al., 2019</xref>; <xref ref-type="bibr" rid="bib9">Bashamboo et al., 2018</xref>). More recently, defects in the external genitalia (micropenis, hypospadias) and cryptorchidism have been associated with rare heterozygous variants in NR2F2 in 46,XY patients (<xref ref-type="bibr" rid="bib80">Zidoune et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Ganapathi et al., 2023</xref>; <xref ref-type="bibr" rid="bib74">Wankanit et al., 2024</xref>). These phenotypes can be attributed to defects in testosterone-dependent masculinization and INSL3-dependent testis descent during gestation and could be explained by a failure of FLC differentiation in the fetal testis. NR2F2 is abundantly expressed in interstitial cells of fetal human testes, a population that likely contains the progenitors for FLC (<xref ref-type="bibr" rid="bib30">Kilcoyne et al., 2014</xref>; <xref ref-type="bibr" rid="bib72">van den Driesche et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Lottrup et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Taelman et al., 2024</xref>). The present work demonstrating that NR2F2 is required in the steroidogenic progenitors of the murine fetal testis for the initiation and progression of FLC differentiation provides an entry point in understanding the etiology of 46,XY DSD associated with pathogenic NR2F2 variants.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Nr2f2</italic></td><td align="left" valign="bottom">MGI</td><td align="left" valign="bottom">MGI:1352452</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Nr2f2<sup>tm1Vc</sup></italic></td><td align="left" valign="bottom">Dr. M. Vasseur-Cognet</td><td align="left" valign="bottom">MGI:3578106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Wt1<sup>tm2(cre/ERT2)Wtp</sup></italic></td><td align="left" valign="bottom">Dr. William T Pu</td><td align="left" valign="bottom">MGI:7528785</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Tg(Nr5a1-cre)2Klp</italic></td><td align="left" valign="bottom">Dr. Keith L Parker</td><td align="left" valign="bottom">MGI:5493455</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound</td><td align="left" valign="bottom">Tamoxifen</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T5648</td><td align="left" valign="bottom">200 mg/kg body weight</td></tr><tr><td align="left" valign="bottom">Chemical compound</td><td align="left" valign="bottom">5-Bromo-2'-deoxy-uridine</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">B5002</td><td align="left" valign="bottom">50 mg/kg body weight</td></tr><tr><td align="left" valign="bottom">Chemical compound</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">EMS</td><td align="char" char="." valign="bottom">15710-S</td><td align="char" char="." valign="bottom">4% in PBS</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ACTA2 (Mouse monoclonal)</td><td align="left" valign="bottom">Gift from Dr. Chaponnier</td><td align="left" valign="bottom"/><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- Activated Caspase 3 (Rabbit polyclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">AF835 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2243952">AB_2243952</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- AMH (Mouse monoclonal)</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">MCA2246 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2226471">AB_2226471</ext-link>)</td><td align="left" valign="bottom">IF (1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- ARX (Rabbit polyclonal)</td><td align="left" valign="bottom">Gift from Pr. Morohashi and Dr. Inoue</td><td align="left" valign="bottom"/><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-COL4A1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab19808 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_445160">AB_445160</ext-link>)</td><td align="left" valign="bottom">IF (1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CYP11A1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Gift from Dr. Wilhelm</td><td align="left" valign="bottom"/><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GATA4 (Goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Sc-1237 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2108747">AB_2108747</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab13970 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_300798">AB_300798</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HSD3B (Goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Sc-30820 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2279878">AB_2279878</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HSD3B (Rabbit polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">PA5-76669 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2720396">AB_2720396</ext-link>)</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ki67 (Rabbit monoclonal)</td><td align="left" valign="bottom">Spring Bioscience</td><td align="left" valign="bottom">M3062 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_11219741">AB_11219741</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-LAMA1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">L9393 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_477163">AB_477163</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NESTIN (Rabbit)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">839801 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2565443">AB_2565443</ext-link>)</td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NR2F2 (Mouse monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">PP-H7147-00 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2155627">AB_2155627</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NR5A1 (Rabbit polyclonal)</td><td align="left" valign="bottom">Cosmo Bio</td><td align="left" valign="bottom">KO611(RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2861370">AB_2861370</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PDGFRA (Rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">SC-338 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_631064">AB_631064</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PECAM-1 (Goat polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Sc-1506 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2161037">AB_2161037</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RUNX1 (Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab92336 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2049267">AB_2049267</ext-link>)</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SOX9 (Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">HPA001758 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_1080067">AB_1080067</ext-link>)</td><td align="left" valign="bottom">IF (1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-WT1 (Goat polyclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">AF5729 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2216239">AB_2216239</ext-link>)</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BrdU detection kit</td><td align="left" valign="bottom">Roche</td><td align="char" char="." valign="bottom">11 296 736 001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNAscope<break/>Multiplex Fluorescent Reagent Kit v2</td><td align="left" valign="bottom">Bio-Techne</td><td align="char" char="." valign="bottom">323110</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gli1</italic> probe</td><td align="left" valign="bottom">Bio-Techne</td><td align="char" char="." valign="bottom">311001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy Micro Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="char" char="." valign="bottom">74004</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SYBR Green I Master</td><td align="left" valign="bottom">Roche</td><td align="char" char="." valign="bottom">04887352001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RefFinder</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.ciidirsinaloa.com.mx/RefFinder-master/?type=reference">https://www.ciidirsinaloa.com.mx/RefFinder-master/?type=reference</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">OMERO</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.openmicroscopy.org/omero/">https://www.openmicroscopy.org/omero/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">Graphpad<break/>Software,<break/>Inc, La Jolla,<break/>CA, USA</td><td align="left" valign="bottom">GraphPad Prism 10.2.1</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse strains and genotyping</title><p>The experiments described herein were carried out in compliance with the guidelines of the French Regulations for Animal Care and with the approval of the local Ethical Committee (APAFIS APAFIS#12789-2017121515109323 v1 and APAFIS#44072-2023061915491990 v5). Mouse lines were kept on a mixed background B6CBAF1/JRj. The <italic>Nr2f2<sup>tm1Vc</sup></italic> line where <italic>Nr2f2</italic> exon 1 sequences (encoding the DNA binding domain) are deleted upon CRE-mediated recombination (referred to as <italic>Nr2f2<sup>flox</sup></italic>), the knock-in <italic>Wt1<sup>tm2(cre/ERT2)Wtp</sup></italic> line where tamoxifen-inducible Cre<sup>ERT2</sup> is produced by WT1 expressing cells (referred to as <italic>Wt1<sup>CreERT2</sup></italic>), and the transgenic <italic>Tg(Nr5a1-cre)2Klp</italic> line where Cre expression is driven by <italic>Nr5a1</italic> regulatory sequences (referred to as <italic>Nr5a1-Cre</italic>) were genotyped as previously described (<xref ref-type="bibr" rid="bib6">Bardoux et al., 2005</xref>; <xref ref-type="bibr" rid="bib79">Zhou et al., 2008</xref>; <xref ref-type="bibr" rid="bib11">Bingham et al., 2006</xref>). <italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/+</sup></italic> or <italic>Nr5a1-Cre</italic><sup>tg/0</sup><italic>; Nr2f2<sup>flox/+</sup></italic> males were crossed with <italic>Nr2f2<sup>flox/+</sup></italic> females to obtain mutant embryos at different stages. Embryos were named controls (<italic>Nr2f2<sup>+/+</sup></italic> or <italic>Nr2f2<sup>flox/+</sup></italic>) or mutants (<italic>Wt1<sup>CreERT2</sup>; Nr2f2<sup>flox/flox</sup></italic> or <italic>Nr5a1-Cre</italic><sup>tg/0</sup><italic>; Nr2f2<sup>flox/flox</sup></italic>). Genotypes of mice and embryos were determined using PCR assays on lysates from ear biopsies or tail tips. Genotyping primers are listed in Appendix 1. To activate the Cre<sup>ERT2</sup> recombinase in embryos, tamoxifen (TAM, T5648, Sigma-Aldrich) was directly diluted in corn oil to a concentration of 40 mg/mL, and two TAM treatments (200 mg/kg body weight) were administered to pregnant females by oral gavage at E9.5 and E10.5. For proliferation assays, 5-bromo-2'-deoxy-uridine (BrdU) (B5002, Sigma-Aldrich) diluted to a concentration of 10 mg/mL in sterile H<sub>2</sub>O was administered to the pregnant females (50 mg/kg body weight) by intraperitoneal injection, and pregnant females and their embryos were humanely killed after 3 hr and 30 min. The day when a vaginal plug was found was designated as E0.5. E11.5–E12.5 embryos were staged by counting the number of ts with 18 ts corresponding to E11.5.</p></sec><sec id="s4-2"><title>Immunofluorescence staining and in situ hybridization</title><p>Embryos were fixed in 4% (wt/vol) paraformaldehyde (PFA, 15,710-S, EMS) overnight, processed for paraffin embedding, and sectioned into 5-µm-thick sections. Immunofluorescence and DAPI staining were performed as described in <xref ref-type="bibr" rid="bib71">Tang et al., 2020</xref>. Proliferation analysis was performed by using a BrdU detection kit (11 296 736 001, Roche). <italic>Gli1</italic> mRNA was detected with the RNAscope technology (probe 311001) according to Advanced Cell’s instructions using the RNAscope Multiplex Fluorescent Reagent Kit v2 Assay. Images were obtained on a motorized Axio Imager Z1 microscope (Zeiss) coupled with an AxioCam MRm camera (Zeiss) and processed with Fiji (Bethesda, MD, USA). The DAPI staining marking the nuclei was adjusted to visualize the tissues and may vary between samples. However, for the immunofluorescence analysis, the exposure time of the acquisition of the fluorescent signal was identical in the same experiment to allow comparison between controls and mutants. Images were assembled using the open-source software platform OMERO (<ext-link ext-link-type="uri" xlink:href="https://www.openmicroscopy.org/omero/">https://www.openmicroscopy.org/omero/</ext-link>). Antibodies are listed in the Key resources table. At least three embryos of each genotype were analyzed for each marker.</p></sec><sec id="s4-3"><title>Cell quantifications</title><p>The gonadal area for each section was measured by creating a gonadal region of interest (ROI) drawn manually in Fiji. The number of HSD3B positive cells (2–493 cells per section depending on the stages and genotypes), SOX9 positive cells (231–882 cells per section depending on the stages and genotypes), NR5A1 positive cells (3–256 cells per section depending on the stages and genotypes), ARX positive cells (666–2487 cells per section depending on the stages and genotypes), ARX positive cells that had incorporated BrdU (232–656 cells per section depending on the stages and genotypes), activated caspase 3 positive cells (0–6 cells per section depending on the stages and genotypes), or the number of nuclei labeled by DAPI (1582–4279 cells per section depending on the stages and genotypes) were counted manually in the entire gonadal section using the Cell Counter Plugin from Fiji. For each genotype, gonads of three or four biological replicates were analyzed. Two to three coronal sections spaced by at least 30 µm in the medial regions of the gonads were analyzed for each individual. Statistical significance was assessed by Mann-Whitney U two-tailed test. * indicates p-value≤0.05; ns indicates p-value&gt;0.05.</p></sec><sec id="s4-4"><title>Quantification of area and circularity of HSD3B positive cells</title><p>Gonadal (ROI) was drawn manually, and HSD3B positive cells were segmented using the Stardist Deep Learning plugin of Fiji with a minimum area of 20 µm<sup>2</sup> to remove small particles. The area and circularity of each segmented cell were measured with Fiji. Circularity = 4π*area/perimeter^2. A value of 1.0 indicates a perfect circle. As the value approaches 0.0, it indicates an increasingly elongated shape. For each genotype, two to three biological replicates were analyzed. The data are shown as violin plots (with median and quartiles) for control and mutant samples.</p></sec><sec id="s4-5"><title>RNA extraction and quantitative PCR analysis</title><p>Individual gonads were dissected from the mesonephros in PBS, snap-frozen in liquid nitrogen, and kept at −80°C. RNA was extracted by RNeasy Micro Kit (74004, QIAGEN) and reverse-transcribed by M-MLV reverse transcriptase (M170A, Promega). The cDNA was used as a template for quantitative PCR analysis using the SYBR Green I Master (04887352001, Roche) and a LightCycler 480 System (Roche). Primer sequences are listed in Appendix 1.</p><p>All biological replicates of different genotypes (N=3–9) were run in the same plate and run as duplicate technical replicates. Relative gene expression of each gonad was normalized to the expression of the housekeeping genes <italic>Shda</italic> and <italic>Tbp</italic> (<xref ref-type="bibr" rid="bib77">Yokoyama et al., 2018</xref>) by the 2-ΔΔCt calculation method. GeNorm, BestKeeper algorithms, and the comparative delta-Ct method provided through the online tool RefFinder (<ext-link ext-link-type="uri" xlink:href="https://www.ciidirsinaloa.com.mx/RefFinder-master/?type=reference">https://www.ciidirsinaloa.com.mx/RefFinder-master/?type=reference</ext-link>#) were used to confirm reference gene stability in the experimental datasets. Fold change in gene expression was obtained by dividing the normalized gene expression in gonads of a given genotype by the mean of the normalized gene expression in control gonads. Data are shown as means ± SEM. Statistical significance was assessed by Mann-Whitney U two-tailed test (GraphPad Prism 10.2.1). * indicates p-value≤0.05; ns indicates p-value&gt;0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Supervision, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The experiments described herein were carried out in compliance with the relevant institutional and French animal welfare laws, guidelines, and policies (APAFIS APAFIS#12789-2017121515109323 v1 and APAFIS#44072-2023061915491990 v5).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-103783-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge the help from members of the Experimental Histopathology Platform, the PRISM Imaging Platform, and the Animal House at iBV (Institut de Biologie Valrose, Université Côte d'Azur, CNRS, Inserm, iBV, France). We are grateful to members of the A Schedl, MC Chaboissier, and S Nef groups for helpful discussions and to D Wilhelm for critical reading of the manuscript. We are indebted to Dr. Chaponnier, Dr. Inoue, Pr Morohashi, Dr. M Vasseur-Cognet, and Dr. Wilhelm for sharing mouse lines and reagents. This research was funded by Agence Nationale de la Recherche ANR-23-CE14-0012, Heterosex, and by a scholarship from the China Scholarship Council (to FT).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ademi</surname><given-names>H</given-names></name><name><surname>Djari</surname><given-names>C</given-names></name><name><surname>Mayère</surname><given-names>C</given-names></name><name><surname>Neirijnck</surname><given-names>Y</given-names></name><name><surname>Sararols</surname><given-names>P</given-names></name><name><surname>Rands</surname><given-names>CM</given-names></name><name><surname>Stévant</surname><given-names>I</given-names></name><name><surname>Conne</surname><given-names>B</given-names></name><name><surname>Nef</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Deciphering the origins and fates of steroidogenic lineages in the mouse testis</article-title><source>Cell Reports</source><volume>39</volume><elocation-id>110935</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110935</pub-id><pub-id pub-id-type="pmid">35705036</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>CM</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>One tool for many jobs: Divergent and conserved actions of androgen signaling in male internal reproductive tract and external genitalia</article-title><source>Frontiers in Endocrinology</source><volume>13</volume><elocation-id>910964</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2022.910964</pub-id><pub-id pub-id-type="pmid">35846302</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>JF</given-names></name><name><surname>Pritchard-Jones</surname><given-names>K</given-names></name><name><surname>Bickmore</surname><given-names>WA</given-names></name><name><surname>Hastie</surname><given-names>ND</given-names></name><name><surname>Bard</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The expression of the Wilms’ tumour gene, WT1, in the developing mammalian embryo</article-title><source>Mechanisms of Development</source><volume>40</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/0925-4773(93)90090-k</pub-id><pub-id pub-id-type="pmid">8382938</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Otake</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Shishido</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C-Y</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Yagi</surname><given-names>M</given-names></name><name><surname>Ishihara</surname><given-names>Y</given-names></name><name><surname>Hino</surname><given-names>S</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Kang</surname><given-names>D</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Chung</surname><given-names>B-C</given-names></name><name><surname>Morohashi</surname><given-names>K-I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3634</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4634</pub-id><pub-id pub-id-type="pmid">24727981</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Otake</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Ishihara</surname><given-names>Y</given-names></name><name><surname>Moon</surname><given-names>J-Y</given-names></name><name><surname>Tsuchiya</surname><given-names>M</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Sato</surname><given-names>R</given-names></name><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>MH</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Morohashi</surname><given-names>K-I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ad4BP/SF-1 regulates cholesterol synthesis to boost the production of steroids</article-title><source>Communications Biology</source><volume>1</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-018-0020-z</pub-id><pub-id pub-id-type="pmid">30271905</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardoux</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Flamez</surname><given-names>D</given-names></name><name><surname>Perilhou</surname><given-names>A</given-names></name><name><surname>Lavin</surname><given-names>TA</given-names></name><name><surname>Tanti</surname><given-names>J-F</given-names></name><name><surname>Hellemans</surname><given-names>K</given-names></name><name><surname>Gomas</surname><given-names>E</given-names></name><name><surname>Godard</surname><given-names>C</given-names></name><name><surname>Andreelli</surname><given-names>F</given-names></name><name><surname>Buccheri</surname><given-names>MA</given-names></name><name><surname>Kahn</surname><given-names>A</given-names></name><name><surname>Le Marchand-Brustel</surname><given-names>Y</given-names></name><name><surname>Burcelin</surname><given-names>R</given-names></name><name><surname>Schuit</surname><given-names>F</given-names></name><name><surname>Vasseur-Cognet</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout</article-title><source>Diabetes</source><volume>54</volume><fpage>1357</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.5.1357</pub-id><pub-id pub-id-type="pmid">15855320</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barsoum</surname><given-names>IB</given-names></name><name><surname>Bingham</surname><given-names>NC</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name><name><surname>Jorgensen</surname><given-names>JS</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Activation of the Hedgehog pathway in the mouse fetal ovary leads to ectopic appearance of fetal Leydig cells and female pseudohermaphroditism</article-title><source>Developmental Biology</source><volume>329</volume><fpage>96</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.02.025</pub-id><pub-id pub-id-type="pmid">19268447</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barsoum</surname><given-names>I</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Redundant and differential roles of transcription factors Gli1 and Gli2 in the development of mouse fetal Leydig cells</article-title><source>Biology of Reproduction</source><volume>84</volume><fpage>894</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.110.088997</pub-id><pub-id pub-id-type="pmid">21209421</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashamboo</surname><given-names>A</given-names></name><name><surname>Eozenou</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>A</given-names></name><name><surname>Bignon-Topalovic</surname><given-names>J</given-names></name><name><surname>Siffroi</surname><given-names>J-P</given-names></name><name><surname>Hyon</surname><given-names>C</given-names></name><name><surname>Tar</surname><given-names>A</given-names></name><name><surname>Nagy</surname><given-names>P</given-names></name><name><surname>Sólyom</surname><given-names>J</given-names></name><name><surname>Halász</surname><given-names>Z</given-names></name><name><surname>Paye-Jaouen</surname><given-names>A</given-names></name><name><surname>Lambert</surname><given-names>S</given-names></name><name><surname>Rodriguez-Buritica</surname><given-names>D</given-names></name><name><surname>Bertalan</surname><given-names>R</given-names></name><name><surname>Martinerie</surname><given-names>L</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name><name><surname>Achermann</surname><given-names>JC</given-names></name><name><surname>McElreavey</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of function of the nuclear receptor NR2F2, encoding COUP-TF2, causes testis development and cardiac defects in 46,XX children</article-title><source>American Journal of Human Genetics</source><volume>102</volume><fpage>487</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.01.021</pub-id><pub-id pub-id-type="pmid">29478779</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielinska</surname><given-names>M</given-names></name><name><surname>Seehra</surname><given-names>A</given-names></name><name><surname>Toppari</surname><given-names>J</given-names></name><name><surname>Heikinheimo</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>GATA-4 is required for sex steroidogenic cell development in the fetal mouse</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21004</pub-id><pub-id pub-id-type="pmid">17096405</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingham</surname><given-names>NC</given-names></name><name><surname>Verma-Kurvari</surname><given-names>S</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Development of a steroidogenic factor 1/Cre transgenic mouse line</article-title><source>Genesis</source><volume>44</volume><fpage>419</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1002/dvg.20231</pub-id><pub-id pub-id-type="pmid">16937416</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Tilmann</surname><given-names>C</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Pdgfr-alpha mediates testis cord organization and fetal Leydig cell development in the XY gonad</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>800</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1101/gad.1052503</pub-id><pub-id pub-id-type="pmid">12651897</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buaas</surname><given-names>FW</given-names></name><name><surname>Gardiner</surname><given-names>JR</given-names></name><name><surname>Clayton</surname><given-names>S</given-names></name><name><surname>Val</surname><given-names>P</given-names></name><name><surname>Swain</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>In vivo evidence for the crucial role of SF1 in steroid-producing cells of the testis, ovary and adrenal gland</article-title><source>Development</source><volume>139</volume><fpage>4561</fpage><lpage>4570</lpage><pub-id pub-id-type="doi">10.1242/dev.087247</pub-id><pub-id pub-id-type="pmid">23136395</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carré</surname><given-names>G-A</given-names></name><name><surname>Siggers</surname><given-names>P</given-names></name><name><surname>Xipolita</surname><given-names>M</given-names></name><name><surname>Brindle</surname><given-names>P</given-names></name><name><surname>Lutz</surname><given-names>B</given-names></name><name><surname>Wells</surname><given-names>S</given-names></name><name><surname>Greenfield</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>190</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx398</pub-id><pub-id pub-id-type="pmid">29145650</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AM</given-names></name><name><surname>Garland</surname><given-names>KK</given-names></name><name><surname>Russell</surname><given-names>LD</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules</article-title><source>Biology of Reproduction</source><volume>63</volume><fpage>1825</fpage><lpage>1838</lpage><pub-id pub-id-type="doi">10.1095/biolreprod63.6.1825</pub-id><pub-id pub-id-type="pmid">11090455</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cool</surname><given-names>J</given-names></name><name><surname>DeFalco</surname><given-names>T</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Testis formation in the fetal mouse: dynamic and complex de novo tubulogenesis</article-title><source>Wiley Interdisciplinary Reviews. Developmental Biology</source><volume>1</volume><fpage>847</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1002/wdev.62</pub-id><pub-id pub-id-type="pmid">23799626</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>S</given-names></name><name><surname>Ross</surname><given-names>A</given-names></name><name><surname>Stallings</surname><given-names>N</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name><name><surname>Quaggin</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice</article-title><source>Development</source><volume>131</volume><fpage>4095</fpage><lpage>4105</lpage><pub-id pub-id-type="doi">10.1242/dev.01266</pub-id><pub-id pub-id-type="pmid">15289436</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFalco</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Two distinct origins for Leydig cell progenitors in the fetal testis</article-title><source>Developmental Biology</source><volume>352</volume><fpage>14</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.01.011</pub-id><pub-id pub-id-type="pmid">21255566</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defalco</surname><given-names>T</given-names></name><name><surname>Saraswathula</surname><given-names>A</given-names></name><name><surname>Briot</surname><given-names>A</given-names></name><name><surname>Iruela-Arispe</surname><given-names>ML</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Testosterone levels influence mouse fetal Leydig cell progenitors through notch signaling</article-title><source>Biology of Reproduction</source><volume>88</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.1095/biolreprod.112.106138</pub-id><pub-id pub-id-type="pmid">23467742</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di-Luoffo</surname><given-names>M</given-names></name><name><surname>Pierre</surname><given-names>KJ</given-names></name><name><surname>Robert</surname><given-names>NM</given-names></name><name><surname>Girard</surname><given-names>MJ</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The nuclear receptors SF1 and COUP-TFII cooperate on the Insl3 promoter in Leydig cells</article-title><source>Reproduction</source><volume>164</volume><fpage>31</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1530/REP-22-0109</pub-id><pub-id pub-id-type="pmid">35666805</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estermann</surname><given-names>MA</given-names></name><name><surname>Grimm</surname><given-names>SA</given-names></name><name><surname>Kitakule</surname><given-names>AS</given-names></name><name><surname>Rodriguez</surname><given-names>KF</given-names></name><name><surname>Brown</surname><given-names>PR</given-names></name><name><surname>McClelland</surname><given-names>K</given-names></name><name><surname>Amato</surname><given-names>CM</given-names></name><name><surname>Yao</surname><given-names>HH-C</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>NR2F2 regulation of interstitial cell fate in the embryonic mouse testis and its impact on differences of sex development</article-title><source>Nature Communications</source><volume>16</volume><elocation-id>3987</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-025-59183-6</pub-id><pub-id pub-id-type="pmid">40295478</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganapathi</surname><given-names>M</given-names></name><name><surname>Matsuoka</surname><given-names>LS</given-names></name><name><surname>March</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Brokamp</surname><given-names>E</given-names></name><name><surname>Benito-Sanz</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>SM</given-names></name><name><surname>Lachlan</surname><given-names>K</given-names></name><name><surname>Ahimaz</surname><given-names>P</given-names></name><name><surname>Sewda</surname><given-names>A</given-names></name><name><surname>Bastarache</surname><given-names>L</given-names></name><name><surname>Thomas-Wilson</surname><given-names>A</given-names></name><name><surname>Stoler</surname><given-names>JM</given-names></name><name><surname>Bramswig</surname><given-names>NC</given-names></name><name><surname>Baptista</surname><given-names>J</given-names></name><name><surname>Stals</surname><given-names>K</given-names></name><name><surname>Demurger</surname><given-names>F</given-names></name><name><surname>Cogne</surname><given-names>B</given-names></name><name><surname>Isidor</surname><given-names>B</given-names></name><name><surname>Bedeschi</surname><given-names>MF</given-names></name><name><surname>Peron</surname><given-names>A</given-names></name><name><surname>Amiel</surname><given-names>J</given-names></name><name><surname>Zackai</surname><given-names>E</given-names></name><name><surname>Schacht</surname><given-names>JP</given-names></name><name><surname>Iglesias</surname><given-names>AD</given-names></name><name><surname>Morton</surname><given-names>J</given-names></name><name><surname>Schmetz</surname><given-names>A</given-names></name><collab>Undiagnosed Diseases Network</collab><name><surname>Seidel</surname><given-names>V</given-names></name><name><surname>Lucia</surname><given-names>S</given-names></name><name><surname>Baskin</surname><given-names>SM</given-names></name><name><surname>Thiffault</surname><given-names>I</given-names></name><name><surname>Cogan</surname><given-names>JD</given-names></name><name><surname>Gordon</surname><given-names>CT</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Bowdin</surname><given-names>S</given-names></name><name><surname>Bhoj</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Heterozygous rare variants in NR2F2 cause a recognizable multiple congenital anomaly syndrome with developmental delays</article-title><source>European Journal of Human Genetics</source><volume>31</volume><fpage>1117</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1038/s41431-023-01434-5</pub-id><pub-id pub-id-type="pmid">37500725</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Maiti</surname><given-names>S</given-names></name><name><surname>Alam</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>JM</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Lécureuil</surname><given-names>C</given-names></name><name><surname>Guillou</surname><given-names>F</given-names></name><name><surname>Huff</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis</article-title><source>PNAS</source><volume>103</volume><fpage>11987</fpage><lpage>11992</lpage><pub-id pub-id-type="doi">10.1073/pnas.0600994103</pub-id><pub-id pub-id-type="pmid">16877546</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cell biology of Leydig cells in the testis</article-title><source>International Review of Cytology</source><volume>233</volume><fpage>181</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S0074-7696(04)33005-6</pub-id><pub-id pub-id-type="pmid">15037365</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutson</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Southwell</surname><given-names>BR</given-names></name><name><surname>Newgreen</surname><given-names>D</given-names></name><name><surname>Cousinery</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of testicular descent</article-title><source>Pediatric Surgery International</source><volume>31</volume><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1007/s00383-015-3673-4</pub-id><pub-id pub-id-type="pmid">25690562</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Tokunaga</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Morohashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Isolation and characterization of fetal leydig progenitor cells of male mice</article-title><source>Endocrinology</source><volume>157</volume><fpage>1222</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1210/en.2015-1773</pub-id><pub-id pub-id-type="pmid">26697723</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>F</given-names></name><name><surname>Terao</surname><given-names>M</given-names></name><name><surname>Yanai</surname><given-names>S</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>D</given-names></name><name><surname>Sugihara</surname><given-names>K</given-names></name><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Takada</surname><given-names>S</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Morohashi</surname><given-names>K-I</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>974</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-03941-5</pub-id><pub-id pub-id-type="pmid">36109592</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeyasuria</surname><given-names>P</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Jamin</surname><given-names>SP</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>De Rooij</surname><given-names>DG</given-names></name><name><surname>Themmen</surname><given-names>APN</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function</article-title><source>Molecular Endocrinology</source><volume>18</volume><fpage>1610</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1210/me.2003-0404</pub-id><pub-id pub-id-type="pmid">15118069</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karl</surname><given-names>J</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Sertoli cells of the mouse testis originate from the coelomic epithelium</article-title><source>Developmental Biology</source><volume>203</volume><fpage>323</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1006/dbio.1998.9068</pub-id><pub-id pub-id-type="pmid">9808783</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilcoyne</surname><given-names>KR</given-names></name><name><surname>Smith</surname><given-names>LB</given-names></name><name><surname>Atanassova</surname><given-names>N</given-names></name><name><surname>Macpherson</surname><given-names>S</given-names></name><name><surname>McKinnell</surname><given-names>C</given-names></name><name><surname>van den Driesche</surname><given-names>S</given-names></name><name><surname>Jobling</surname><given-names>MS</given-names></name><name><surname>Chambers</surname><given-names>TJG</given-names></name><name><surname>De Gendt</surname><given-names>K</given-names></name><name><surname>Verhoeven</surname><given-names>G</given-names></name><name><surname>O’Hara</surname><given-names>L</given-names></name><name><surname>Platts</surname><given-names>S</given-names></name><name><surname>Renato de Franca</surname><given-names>L</given-names></name><name><surname>Lara</surname><given-names>NLM</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Sharpe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fetal programming of adult Leydig cell function by androgenic effects on stem/progenitor cells</article-title><source>PNAS</source><volume>111</volume><fpage>E1924</fpage><lpage>E1932</lpage><pub-id pub-id-type="doi">10.1073/pnas.1320735111</pub-id><pub-id pub-id-type="pmid">24753613</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kothandapani</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>SR</given-names></name><name><surname>Noel</surname><given-names>JL</given-names></name><name><surname>Zacharski</surname><given-names>A</given-names></name><name><surname>Krellwitz</surname><given-names>K</given-names></name><name><surname>Baines</surname><given-names>A</given-names></name><name><surname>Winske</surname><given-names>S</given-names></name><name><surname>Vezina</surname><given-names>CM</given-names></name><name><surname>Kaftanovskaya</surname><given-names>EM</given-names></name><name><surname>Agoulnik</surname><given-names>AI</given-names></name><name><surname>Merton</surname><given-names>EM</given-names></name><name><surname>Cohn</surname><given-names>MJ</given-names></name><name><surname>Jorgensen</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>GLI3 resides at the intersection of hedgehog and androgen action to promote male sex differentiation</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008810</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008810</pub-id><pub-id pub-id-type="pmid">32497091</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>DL</given-names></name><name><surname>DeFalco</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A perivascular niche for multipotent progenitors in the fetal testis</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4519</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06996-3</pub-id><pub-id pub-id-type="pmid">30375389</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Jeong</surname><given-names>J</given-names></name><name><surname>Kwak</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>C-T</given-names></name><name><surname>Lanske</surname><given-names>B</given-names></name><name><surname>Soegiarto</surname><given-names>DW</given-names></name><name><surname>Toftgard</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>M-J</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus</article-title><source>Nature Genetics</source><volume>38</volume><fpage>1204</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1038/ng1874</pub-id><pub-id pub-id-type="pmid">16951680</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S-Y</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Heinrich</surname><given-names>A</given-names></name><name><surname>Hurley</surname><given-names>EG</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name><name><surname>DeFalco</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of Mafb and Maf distorts myeloid cell ratios and disrupts fetal mouse testis vascularization and organogenesis†</article-title><source>Biology of Reproduction</source><volume>105</volume><fpage>958</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioab098</pub-id><pub-id pub-id-type="pmid">34007995</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Rodriguez</surname><given-names>K</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mapping lineage progression of somatic progenitor cells in the mouse fetal testis</article-title><source>Development</source><volume>143</volume><fpage>3700</fpage><lpage>3710</lpage><pub-id pub-id-type="doi">10.1242/dev.135756</pub-id><pub-id pub-id-type="pmid">27621062</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lottrup</surname><given-names>G</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>Maroun</surname><given-names>LL</given-names></name><name><surname>Møller</surname><given-names>LMA</given-names></name><name><surname>Yassin</surname><given-names>M</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Skakkebæk</surname><given-names>NE</given-names></name><name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome</article-title><source>Human Reproduction</source><volume>29</volume><fpage>1637</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1093/humrep/deu124</pub-id><pub-id pub-id-type="pmid">24908673</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuylov</surname><given-names>NL</given-names></name><name><surname>Smagulova</surname><given-names>FO</given-names></name><name><surname>Leach</surname><given-names>L</given-names></name><name><surname>Tevosian</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ovarian development in mice requires the GATA4-FOG2 transcription complex</article-title><source>Development</source><volume>135</volume><fpage>3731</fpage><lpage>3743</lpage><pub-id pub-id-type="doi">10.1242/dev.024653</pub-id><pub-id pub-id-type="pmid">18927154</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuylov</surname><given-names>NL</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Fox</surname><given-names>SC</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Tevosian</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Conditional ablation of Gata4 and Fog2 genes in mice reveals their distinct roles in mammalian sexual differentiation</article-title><source>Developmental Biology</source><volume>353</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.02.032</pub-id><pub-id pub-id-type="pmid">21385577</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayère</surname><given-names>C</given-names></name><name><surname>Regard</surname><given-names>V</given-names></name><name><surname>Perea-Gomez</surname><given-names>A</given-names></name><name><surname>Bunce</surname><given-names>C</given-names></name><name><surname>Neirijnck</surname><given-names>Y</given-names></name><name><surname>Djari</surname><given-names>C</given-names></name><name><surname>Bellido-Carreras</surname><given-names>N</given-names></name><name><surname>Sararols</surname><given-names>P</given-names></name><name><surname>Reeves</surname><given-names>R</given-names></name><name><surname>Greenaway</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><name><surname>Siggers</surname><given-names>P</given-names></name><name><surname>Condrea</surname><given-names>D</given-names></name><name><surname>Kühne</surname><given-names>F</given-names></name><name><surname>Gantar</surname><given-names>I</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Stévant</surname><given-names>I</given-names></name><name><surname>Batti</surname><given-names>L</given-names></name><name><surname>Ghyselinck</surname><given-names>NB</given-names></name><name><surname>Wilhelm</surname><given-names>D</given-names></name><name><surname>Greenfield</surname><given-names>A</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name><name><surname>Chaboissier</surname><given-names>M-C</given-names></name><name><surname>Nef</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Origin, specification and differentiation of a rare supporting-like lineage in the developing mouse gonad</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabm0972</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abm0972</pub-id><pub-id pub-id-type="pmid">35613264</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehanovic</surname><given-names>S</given-names></name><name><surname>Mendoza-Villarroel</surname><given-names>RE</given-names></name><name><surname>de Mattos</surname><given-names>K</given-names></name><name><surname>Talbot</surname><given-names>P</given-names></name><name><surname>Viger</surname><given-names>RS</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Identification of novel genes and pathways regulated by the orphan nuclear receptor COUP-TFII in mouse MA-10 Leydig cells†</article-title><source>Biology of Reproduction</source><volume>105</volume><fpage>1283</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioab131</pub-id><pub-id pub-id-type="pmid">34225363</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehanovic</surname><given-names>S</given-names></name><name><surname>Pierre</surname><given-names>KJ</given-names></name><name><surname>Viger</surname><given-names>RS</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Chicken ovalbumin upstream promoter transcription factor type II interacts and functionally cooperates with GATA4 to regulate anti-Müllerian hormone receptor type 2 transcription in mouse MA-10 Leydig cells</article-title><source>Andrology</source><volume>10</volume><fpage>1411</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1111/andr.13266</pub-id><pub-id pub-id-type="pmid">35973717</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Villarroel</surname><given-names>RE</given-names></name><name><surname>Di-Luoffo</surname><given-names>M</given-names></name><name><surname>Camiré</surname><given-names>E</given-names></name><name><surname>Giner</surname><given-names>XC</given-names></name><name><surname>Brousseau</surname><given-names>C</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>The INSL3 gene is a direct target for the orphan nuclear receptor, COUP-TFII, in Leydig cells</article-title><source>Journal of Molecular Endocrinology</source><volume>53</volume><fpage>43</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1530/JME-13-0290</pub-id><pub-id pub-id-type="pmid">24780841</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Villarroel</surname><given-names>RE</given-names></name><name><surname>Robert</surname><given-names>NM</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Brousseau</surname><given-names>C</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>The nuclear receptor NR2F2 activates star expression and steroidogenesis in mouse MA-10 and MLTC-1 Leydig cells</article-title><source>Biology of Reproduction</source><volume>91</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.1095/biolreprod.113.115790</pub-id><pub-id pub-id-type="pmid">24899578</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Katoh-Fukui</surname><given-names>Y</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Sugiyama</surname><given-names>N</given-names></name><name><surname>Kitamura</surname><given-names>K</given-names></name><name><surname>Morohashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aristaless related homeobox gene, Arx, is implicated in mouse fetal Leydig cell differentiation possibly through expressing in the progenitor cells</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e68050</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0068050</pub-id><pub-id pub-id-type="pmid">23840809</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Morohashi</surname><given-names>K-I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Alterations in fetal Leydig cell gene expression during fetal and adult development</article-title><source>Sexual Development</source><volume>11</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1159/000453323</pub-id><pub-id pub-id-type="pmid">27960177</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morohashi</surname><given-names>KI</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coordination of multiple cellular processes by NR5A1/NR5A1</article-title><source>Endocrinology and Metabolism</source><volume>35</volume><fpage>756</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.3803/EnM.2020.402</pub-id><pub-id pub-id-type="pmid">33397036</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nef</surname><given-names>S</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Cryptorchidism in mice mutant for Insl3</article-title><source>Nature Genetics</source><volume>22</volume><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/10364</pub-id><pub-id pub-id-type="pmid">10391220</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicol</surname><given-names>B</given-names></name><name><surname>Grimm</surname><given-names>SA</given-names></name><name><surname>Chalmel</surname><given-names>F</given-names></name><name><surname>Lecluze</surname><given-names>E</given-names></name><name><surname>Pannetier</surname><given-names>M</given-names></name><name><surname>Pailhoux</surname><given-names>E</given-names></name><name><surname>Dupin-De-Beyssat</surname><given-names>E</given-names></name><name><surname>Guiguen</surname><given-names>Y</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name><name><surname>Yao</surname><given-names>HH-C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5116</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13060-1</pub-id><pub-id pub-id-type="pmid">31712577</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Shaughnessy</surname><given-names>PJ</given-names></name><name><surname>Baker</surname><given-names>PJ</given-names></name><name><surname>Heikkilä</surname><given-names>M</given-names></name><name><surname>Vainio</surname><given-names>S</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis--androstenedione is the major androgen secreted by fetal/neonatal leydig cells</article-title><source>Endocrinology</source><volume>141</volume><fpage>2631</fpage><lpage>2637</lpage><pub-id pub-id-type="doi">10.1210/endo.141.7.7545</pub-id><pub-id pub-id-type="pmid">10875268</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padua</surname><given-names>MB</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Morse</surname><given-names>DA</given-names></name><name><surname>Fox</surname><given-names>SC</given-names></name><name><surname>Hatch</surname><given-names>HM</given-names></name><name><surname>Tevosian</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Combined loss of the GATA4 and GATA6 transcription factors in male mice disrupts testicular development and confers adrenal-like function in the testes</article-title><source>Endocrinology</source><volume>156</volume><fpage>1873</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.1210/en.2014-1907</pub-id><pub-id pub-id-type="pmid">25668066</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HL</given-names></name><name><surname>Bai</surname><given-names>C</given-names></name><name><surname>Platt</surname><given-names>KA</given-names></name><name><surname>Matise</surname><given-names>MP</given-names></name><name><surname>Beeghly</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>CC</given-names></name><name><surname>Nakashima</surname><given-names>M</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation</article-title><source>Development</source><volume>127</volume><fpage>1593</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1242/dev.127.8.1593</pub-id><pub-id pub-id-type="pmid">10725236</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>FA</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>1037</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1101/gad.13.8.1037</pub-id><pub-id pub-id-type="pmid">10215630</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierucci-Alves</surname><given-names>F</given-names></name><name><surname>Clark</surname><given-names>AM</given-names></name><name><surname>Russell</surname><given-names>LD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A developmental study of the Desert hedgehog-null mouse testis</article-title><source>Biology of Reproduction</source><volume>65</volume><fpage>1392</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1095/biolreprod65.5.1392</pub-id><pub-id pub-id-type="pmid">11673255</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polvani</surname><given-names>S</given-names></name><name><surname>Pepe</surname><given-names>S</given-names></name><name><surname>Milani</surname><given-names>S</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>COUP-TFII in health and disease</article-title><source>Cells</source><volume>9</volume><elocation-id>101</elocation-id><pub-id pub-id-type="doi">10.3390/cells9010101</pub-id><pub-id pub-id-type="pmid">31906104</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Essential roles of COUP-TFII in Leydig cell differentiation and male fertility</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3285</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003285</pub-id><pub-id pub-id-type="pmid">18818749</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>AP</given-names></name><name><surname>León</surname><given-names>NY</given-names></name><name><surname>Frost</surname><given-names>ER</given-names></name><name><surname>Harley</surname><given-names>VR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Genetic control of typical and atypical sex development</article-title><source>Nature Reviews. Urology</source><volume>20</volume><fpage>434</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/s41585-023-00754-x</pub-id><pub-id pub-id-type="pmid">37020056</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotgers</surname><given-names>E</given-names></name><name><surname>Jørgensen</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>At the crossroads of fate-somatic cell lineage specification in the fetal gonad</article-title><source>Endocrine Reviews</source><volume>39</volume><fpage>739</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1210/er.2018-00010</pub-id><pub-id pub-id-type="pmid">29771299</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sararols</surname><given-names>P</given-names></name><name><surname>Stévant</surname><given-names>I</given-names></name><name><surname>Neirijnck</surname><given-names>Y</given-names></name><name><surname>Rebourcet</surname><given-names>D</given-names></name><name><surname>Darbey</surname><given-names>A</given-names></name><name><surname>Curley</surname><given-names>MK</given-names></name><name><surname>Kühne</surname><given-names>F</given-names></name><name><surname>Dermitzakis</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>LB</given-names></name><name><surname>Nef</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Specific transcriptomic signatures and dual regulation of steroidogenesis between fetal and adult mouse Leydig cells</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>695546</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.695546</pub-id><pub-id pub-id-type="pmid">34262907</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmahl</surname><given-names>J</given-names></name><name><surname>Rizzolo</surname><given-names>K</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The PDGF signaling pathway controls multiple steroid-producing lineages</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>3255</fpage><lpage>3267</lpage><pub-id pub-id-type="doi">10.1101/gad.1723908</pub-id><pub-id pub-id-type="pmid">19056881</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnabel</surname><given-names>CA</given-names></name><name><surname>Selleri</surname><given-names>L</given-names></name><name><surname>Cleary</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Pbx1 is essential for adrenal development and urogenital differentiation</article-title><source>Genesis</source><volume>37</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1002/gene.10235</pub-id><pub-id pub-id-type="pmid">14595835</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>CL</given-names></name><name><surname>Christiansen</surname><given-names>S</given-names></name><name><surname>Vinggaard</surname><given-names>AM</given-names></name><name><surname>Axelstad</surname><given-names>M</given-names></name><name><surname>Hass</surname><given-names>U</given-names></name><name><surname>Svingen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders</article-title><source>Archives of Toxicology</source><volume>93</volume><fpage>253</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1007/s00204-018-2350-5</pub-id><pub-id pub-id-type="pmid">30430187</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Haraguchi</surname><given-names>S</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Otake</surname><given-names>H</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Matsuzaki</surname><given-names>S</given-names></name><name><surname>Shishido</surname><given-names>Y</given-names></name><name><surname>Akiyama</surname><given-names>H</given-names></name><name><surname>Tachibana</surname><given-names>T</given-names></name><name><surname>Tsutsui</surname><given-names>K</given-names></name><name><surname>Morohashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Contribution of Leydig and Sertoli cells to testosterone production in mouse fetal testes</article-title><source>Molecular Endocrinology</source><volume>27</volume><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1210/me.2012-1256</pub-id><pub-id pub-id-type="pmid">23125070</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Morohashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Leydig progenitor cells in fetal testis</article-title><source>Molecular and Cellular Endocrinology</source><volume>445</volume><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2016.12.006</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Doi</surname><given-names>M</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fetal Leydig cells dedifferentiate and serve as adult Leydig stem cells</article-title><source>Development</source><volume>145</volume><elocation-id>dev169136</elocation-id><pub-id pub-id-type="doi">10.1242/dev.169136</pub-id><pub-id pub-id-type="pmid">30518625</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development of fetal and adult Leydig cells</article-title><source>Reproductive Medicine and Biology</source><volume>18</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1002/rmb2.12287</pub-id><pub-id pub-id-type="pmid">31607792</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stévant</surname><given-names>I</given-names></name><name><surname>Neirijnck</surname><given-names>Y</given-names></name><name><surname>Borel</surname><given-names>C</given-names></name><name><surname>Escoffier</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>LB</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Nef</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deciphering cell lineage specification during male sex determination with single-cell RNA sequencing</article-title><source>Cell Reports</source><volume>22</volume><fpage>1589</fpage><lpage>1599</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.01.043</pub-id><pub-id pub-id-type="pmid">29425512</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stévant</surname><given-names>I</given-names></name><name><surname>Kühne</surname><given-names>F</given-names></name><name><surname>Greenfield</surname><given-names>A</given-names></name><name><surname>Chaboissier</surname><given-names>M-C</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Nef</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dissecting cell lineage specification and sex fate determination in gonadal somatic cells using single-cell transcriptomics</article-title><source>Cell Reports</source><volume>26</volume><fpage>3272</fpage><lpage>3283</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.069</pub-id><pub-id pub-id-type="pmid">30893600</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swift</surname><given-names>MR</given-names></name><name><surname>Pham</surname><given-names>VN</given-names></name><name><surname>Castranova</surname><given-names>D</given-names></name><name><surname>Bell</surname><given-names>K</given-names></name><name><surname>Poole</surname><given-names>RJ</given-names></name><name><surname>Weinstein</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SoxF factors and Notch regulate nr2f2 gene expression during venous differentiation in zebrafish</article-title><source>Developmental Biology</source><volume>390</volume><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.03.018</pub-id><pub-id pub-id-type="pmid">24699544</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taelman</surname><given-names>J</given-names></name><name><surname>Czukiewska</surname><given-names>SM</given-names></name><name><surname>Moustakas</surname><given-names>I</given-names></name><name><surname>Chang</surname><given-names>YW</given-names></name><name><surname>Hillenius</surname><given-names>S</given-names></name><name><surname>van der Helm</surname><given-names>T</given-names></name><name><surname>van der Meeren</surname><given-names>LE</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Chuva de Sousa Lopes</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Characterization of the human fetal gonad and reproductive tract by single-cell transcriptomics</article-title><source>Developmental Cell</source><volume>59</volume><fpage>529</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2024.01.006</pub-id><pub-id pub-id-type="pmid">38295793</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Karl</surname><given-names>J</given-names></name><name><surname>Hamada</surname><given-names>Y</given-names></name><name><surname>Raetzman</surname><given-names>L</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Notch signaling maintains Leydig progenitor cells in the mouse testis</article-title><source>Development</source><volume>135</volume><fpage>3745</fpage><lpage>3753</lpage><pub-id pub-id-type="doi">10.1242/dev.024786</pub-id><pub-id pub-id-type="pmid">18927153</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Richardson</surname><given-names>N</given-names></name><name><surname>Albina</surname><given-names>A</given-names></name><name><surname>Chaboissier</surname><given-names>MC</given-names></name><name><surname>Perea-Gomez</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mouse gonad development in the absence of the pro-ovary factor WNT4 and the pro-testis factor SOX9</article-title><source>Cells</source><volume>9</volume><elocation-id>1103</elocation-id><pub-id pub-id-type="doi">10.3390/cells9051103</pub-id><pub-id pub-id-type="pmid">32365547</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Driesche</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>McKinnell</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>HM</given-names></name><name><surname>Eddie</surname><given-names>SL</given-names></name><name><surname>Mitchell</surname><given-names>RT</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Drake</surname><given-names>AJ</given-names></name><name><surname>Smith</surname><given-names>LB</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Sharpe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Proposed Role for COUP-TFII in regulating fetal Leydig cell steroidogenesis, perturbation of which leads to masculinization disorders in rodents</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e37064</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0037064</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viger</surname><given-names>RS</given-names></name><name><surname>de Mattos</surname><given-names>K</given-names></name><name><surname>Tremblay</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Insights Into the roles of GATA factors in mammalian testis development and the control of fetal testis gene expression</article-title><source>Frontiers in Endocrinology</source><volume>13</volume><elocation-id>902198</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2022.902198</pub-id><pub-id pub-id-type="pmid">35692407</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wankanit</surname><given-names>S</given-names></name><name><surname>Zidoune</surname><given-names>H</given-names></name><name><surname>Bignon-Topalovic</surname><given-names>J</given-names></name><name><surname>Schlick</surname><given-names>L</given-names></name><name><surname>Houzelstein</surname><given-names>D</given-names></name><name><surname>Fusée</surname><given-names>L</given-names></name><name><surname>Boukri</surname><given-names>A</given-names></name><name><surname>Nouri</surname><given-names>N</given-names></name><name><surname>McElreavey</surname><given-names>K</given-names></name><name><surname>Bashamboo</surname><given-names>A</given-names></name><name><surname>Elzaiat</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Evidence for NR2F2/COUP-TFII involvement in human testis development</article-title><source>Scientific Reports</source><volume>14</volume><elocation-id>17869</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-024-68860-3</pub-id><pub-id pub-id-type="pmid">39090159</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>Y-X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development, function and fate of fetal Leydig cells</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>59</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2016.03.003</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>HHC</given-names></name><name><surname>Whoriskey</surname><given-names>W</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>1433</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1101/gad.981202</pub-id><pub-id pub-id-type="pmid">12050120</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Omotehara</surname><given-names>T</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>N</given-names></name><name><surname>Yanai</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>C</given-names></name><name><surname>Takada</surname><given-names>T</given-names></name><name><surname>Mantani</surname><given-names>Y</given-names></name><name><surname>Hoshi</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of reference genes for quantitative PCR analyses in developing mouse gonads</article-title><source>The Journal of Veterinary Medical Science</source><volume>80</volume><fpage>1534</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1292/jvms.18-0417</pub-id><pub-id pub-id-type="pmid">30175754</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C-T</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Suh</surname><given-names>JM</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>M-J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>COUP-TFII is essential for metanephric mesenchyme formation and kidney precursor cell survival</article-title><source>Development</source><volume>139</volume><fpage>2330</fpage><lpage>2339</lpage><pub-id pub-id-type="doi">10.1242/dev.076299</pub-id><pub-id pub-id-type="pmid">22669823</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Rajagopal</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>SM</given-names></name><name><surname>Domian</surname><given-names>I</given-names></name><name><surname>Rivera-Feliciano</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>von Gise</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><name><surname>Chien</surname><given-names>KR</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart</article-title><source>Nature</source><volume>454</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/nature07060</pub-id><pub-id pub-id-type="pmid">18568026</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zidoune</surname><given-names>H</given-names></name><name><surname>Ladjouze</surname><given-names>A</given-names></name><name><surname>Chellat-Rezgoune</surname><given-names>D</given-names></name><name><surname>Boukri</surname><given-names>A</given-names></name><name><surname>Dib</surname><given-names>SA</given-names></name><name><surname>Nouri</surname><given-names>N</given-names></name><name><surname>Tebibel</surname><given-names>M</given-names></name><name><surname>Sifi</surname><given-names>K</given-names></name><name><surname>Abadi</surname><given-names>N</given-names></name><name><surname>Satta</surname><given-names>D</given-names></name><name><surname>Benelmadani</surname><given-names>Y</given-names></name><name><surname>Bignon-Topalovic</surname><given-names>J</given-names></name><name><surname>El-Zaiat-Munsch</surname><given-names>M</given-names></name><name><surname>Bashamboo</surname><given-names>A</given-names></name><name><surname>McElreavey</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Novel genomic variants, atypical phenotypes and evidence of a Digenic/Oligogenic contribution to disorders/differences of sex development in a large North African cohort</article-title><source>Frontiers in Genetics</source><volume>13</volume><elocation-id>900574</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2022.900574</pub-id><pub-id pub-id-type="pmid">36110220</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Steding</surname><given-names>G</given-names></name><name><surname>Emmen</surname><given-names>JM</given-names></name><name><surname>Brinkmann</surname><given-names>AO</given-names></name><name><surname>Nayernia</surname><given-names>K</given-names></name><name><surname>Holstein</surname><given-names>AF</given-names></name><name><surname>Engel</surname><given-names>W</given-names></name><name><surname>Adham</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Targeted disruption of the Insl3 gene causes bilateral cryptorchidism</article-title><source>Molecular Endocrinology</source><volume>13</volume><fpage>681</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1210/mend.13.5.0272</pub-id><pub-id pub-id-type="pmid">10319319</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>Primers</title><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Primer name</th><th align="left" valign="top">Application</th><th align="left" valign="top">Sequence (5’-3’)</th></tr></thead><tbody><tr><td align="left" valign="top">CRE 1</td><td align="left" valign="top">Genotyping <italic>Cre</italic></td><td align="left" valign="top"><named-content content-type="sequence">CAGGATATACGTAATCTGGC</named-content></td></tr><tr><td align="left" valign="top">CRE 4</td><td align="left" valign="top">Genotyping <italic>Cre</italic></td><td align="left" valign="top"><named-content content-type="sequence">CACGGGCACTGTGTCCAGACCAG</named-content></td></tr><tr><td align="left" valign="top">CCR5mR</td><td align="left" valign="top">Genotyping internal control</td><td align="left" valign="top"><named-content content-type="sequence">ATGTGGATGGAGAGGAGTCG</named-content></td></tr><tr><td align="left" valign="top">CCR5mL</td><td align="left" valign="top">Genotyping internal control</td><td align="left" valign="top"><named-content content-type="sequence">CAACCGAGACCTTCCTGTTC</named-content></td></tr><tr><td align="left" valign="top">TF2.1</td><td align="left" valign="top">Genotyping <italic>Nr2f2</italic></td><td align="left" valign="top"><named-content content-type="sequence">TGCCCACACTTTCCTACTCC</named-content></td></tr><tr><td align="left" valign="top">TF2.5</td><td align="left" valign="top">Genotyping <italic>Nr2f2</italic></td><td align="left" valign="top"><named-content content-type="sequence">TTTCTGCAAGGAATGGGTTG</named-content></td></tr><tr><td align="left" valign="top"><italic>Amh-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GGGGAGACTGGAGAACAGC</named-content></td></tr><tr><td align="left" valign="top"><italic>Amh-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">AGAGCTCGGGCTCCCATA</named-content></td></tr><tr><td align="left" valign="top"><italic>Arx-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GCACCACGTTCACCAGTTAC</named-content></td></tr><tr><td align="left" valign="top"><italic>Arx-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GCACCACGTTCACCAGTTAC</named-content></td></tr><tr><td align="left" valign="top"><italic>Bhmt-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CGTCAGCTTCATCGGGAGTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Bhmt-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CTTGCCGTGCAATGTCACAA</named-content></td></tr><tr><td align="left" valign="top"><italic>Cdh5-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TCCTCTGCATCCTCACCATCACA</named-content></td></tr><tr><td align="left" valign="top"><italic>Cdh5-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GTAAGTGACCAACTGCTCGTGAAT</named-content></td></tr><tr><td align="left" valign="top"><italic>Cyp11a1-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TGGCCCCATTTACAGGGAGAA</named-content></td></tr><tr><td align="left" valign="top"><italic>Cyp11a1-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GGCATCTGAACTCTTAAACAGGA</named-content></td></tr><tr><td align="left" valign="top"><italic>Cyp17a1-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CAGAGAAGTGCTCGTGAAGAAG</named-content></td></tr><tr><td align="left" valign="top"><italic>Cyp17a1Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CAGAGAAGTGCTCGTGAAGAAG</named-content></td></tr><tr><td align="left" valign="top"><italic>Dhh-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GGACCTCGTACCCAACTACAA</named-content></td></tr><tr><td align="left" valign="top"><italic>Dhh-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CGATGGCTAGAGCGTTCACC</named-content></td></tr><tr><td align="left" valign="top"><italic>Gli1-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TGGTACCATGAGCCCTTCTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Gli1-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GTGGTACACAGGGCTGGACT</named-content></td></tr><tr><td align="left" valign="top"><italic>Hes1-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">ATAGCTCCCGGCATTCCAAG</named-content></td></tr><tr><td align="left" valign="top"><italic>Hes1-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">ATAGCTCCCGGCATTCCAAG</named-content></td></tr><tr><td align="left" valign="top"><italic>HeyL-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CAGCCCTTCGCAGATGCAA</named-content></td></tr><tr><td align="left" valign="top"><italic>HeyL-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CCAATCGTCGCAATTCAGAAAG</named-content></td></tr><tr><td align="left" valign="top"><italic>Insl3-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">ATTGCTCCCCACCTCCTGGCTATG</named-content></td></tr><tr><td align="left" valign="top"><italic>Insl3-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GGTCATGATGGGGCTTCTTGGGGA</named-content></td></tr><tr><td align="left" valign="top"><italic>Notch2-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">ATATCGACGACTGCCCCAAC</named-content></td></tr><tr><td align="left" valign="top"><italic>Notch2-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CCATAGCCTCCGTTTCGGTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Nr2f2-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CGGAGGAACCTGAGCTACAC</named-content></td></tr><tr><td align="left" valign="top"><italic>Nr2f2-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CGGAGGAACCTGAGCTACAC</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfa-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CAGTGTCAAGGTGGCCAAAGT</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfa-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CAGTGTCAAGGTGGCCAAAGT</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfb-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GATCTCTCGGAACCTCATCG</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfb-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GATCTCTCGGAACCTCATCG</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfra-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TCCATGCTAGACTCAGAAGTCA</named-content></td></tr><tr><td align="left" valign="top"><italic>Pdgfra-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TCCCGGTGGACACAATTTTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Sdha-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TGTTCAGTTCCACCCCACA</named-content></td></tr><tr><td align="left" valign="top"><italic>Sdha-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TCTCCACGACACCCTTCTG</named-content></td></tr><tr><td align="left" valign="top"><italic>Sgpl1-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CTGAAGGACTTCGAGCCTTATTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Sgpl1-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">CTGAAGGACTTCGAGCCTTATTT</named-content></td></tr><tr><td align="left" valign="top"><italic>Sox9-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GCGGAGCTCAGCAAGACTCTG</named-content></td></tr><tr><td align="left" valign="top"><italic>Sox9-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">ATCGGGGTGGTCTTTCTTGTG</named-content></td></tr><tr><td align="left" valign="top"><italic>Tbp-Fwd</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">GCTCTGGAATTGTACCGCAG</named-content></td></tr><tr><td align="left" valign="top"><italic>Tbp-Rev</italic></td><td align="left" valign="top">RT-qPCR primers</td><td align="left" valign="top"><named-content content-type="sequence">TGACTGCAGCAAATCGCTTG</named-content></td></tr></tbody></table></table-wrap></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103783.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Weigel</surname><given-names>Detlef</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Max Planck Institute for Biology Tübingen</institution><country>Germany</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study, which has been improved further upon revision, reveals a critical role of the transcription factor NR2F2 in mouse fetal Leydig cell (FLC) differentiation. With elegantly carried out experiments, the authors provide <bold>compelling</bold> evidence that NR2F2 helps to initiate the differentiation of certain interstitial cells into FLC until these cells mature into functional secretory cells that produce androgen and insulin-like peptide 3 (INSL3). The particular importance of the work comes from the fact that NR2F2 affects FLCs without altering paracrine signals known to be involved in FLC differentiation. The work will be of interest to colleagues studying reproductive development in mammals including humans or the biological functions of the nuclear receptor family.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103783.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this beautiful paper the authors examined the role and function of NR2F2 in testis development and more specifically on fetal Leydig cells development. It is well known by now that FLC are developed from an interstitial steroidogenic progenitor at around E12.5 and are crucial for testosterone and INSL3 production during embryonic development, which in turn shapes the internal and external genitalia of the male. Indeed, lack of testosterone or INSL3 are known to cause DSD as well as undescended testis, also termed as cryptorchidism.</p><p>The authors first characterized the expression pattern of the NR2R2 protein during testis development and then used two cKO systems of NR2F2, namely the Wt1-creERT2 and the Nr5a1-cre to explore the phenotype of loss of NR2F2. They found in both cases that mice are presenting with undescended testis and major reduction in FLC numbers. They show that NR2F2 has no effect on the amount and expression of the progenitor cells but in its absence, there are less FLC and they are immature.</p><p>The effect of NR2F2 is cell autonomous and does not seem to affect other signalling pathways implemented in Leydig cell development as the DHH, PDGFRA and the NOTCH pathway.</p><p>Overall, this paper is excellent, very well written, fluent and clear. The data is well presented, and all the controls and statistics are in place. I think this paper will be of great interest to the field and paves the way for several interesting follow up studies as stated in the discussion</p><p>Comments on revised version:</p><p>The authors have fully addressed my concerns and the manuscript is looking excellent.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103783.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The major conclusion of the manuscript is expressed in the title: &quot;NR2F2 is required in the embryonic testis for Fetal Leydig Cell development&quot; and also at the end of the introduction and all along the result part. All the authors' assertions are supported by very clear and statistically validated results from ISH, IHC, precise cell counting and gene expression levels by qPCR. The authors used two different conditional Nr2f2 gene ablation systems that demonstrate the same effects at the FLC level. They also showed that the haplo-insufficiency of Wt1 in the first system (knock-in Wt1-cre-ERT2) aggravated the situation in FLC differentiation by disturbing the differentiation of Sertoli cells and their secretion of pro-FLC factors, which had a confounding effect and encouraged them to use the second system. This demonstrates the great rigor with which the authors interpreted the results. In conclusion, all authors' claims and conclusions are justified by their high-quality results.</p><p>Comments on revised version:</p><p>In their revised version, the authors have taken full account of all my suggestions, and I congratulate them on this. I have no further comments to make on this new version.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.103783.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Perea-Gomez</surname><given-names>Aitana</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Biology Valrose</institution><addr-line><named-content content-type="city">NICE</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Bellido Carreras</surname><given-names>Natividad</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Biology Valrose</institution><addr-line><named-content content-type="city">NICE</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Dhellemmes</surname><given-names>Magali</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Biology Valrose</institution><addr-line><named-content content-type="city">NICE</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Furong</given-names></name><role specific-use="author">Author</role><aff><institution>University of Electronic Science and Technology of China</institution></aff></contrib><contrib contrib-type="author"><name><surname>Le Gallo</surname><given-names>Coralie</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Biology Valrose</institution><addr-line><named-content content-type="city">NICE</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Chaboissier</surname><given-names>Marie-Christine</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Biology Valrose</institution><addr-line><named-content content-type="city">NICE</named-content></addr-line><country>France</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary</p><p>In this beautiful paper the authors examined the role and function of NR2F2 in testis development and more specifically on fetal Leydig cells development. It is well known by now that FLC are developed from an interstitial steroidogenic progenitors at around E12.5 and are crucial for testosterone and INSL3 production during embryonic development, which in turn shapes the internal and external genitalia of the male. Indeed, lack of testosterone or INSL3 are known to cause DSD as well as undescended testis, also termed as cryptorchidism. The authors first characterized the expression pattern of the NR2R2 protein during testis development and then used two cKO systems of NR2F2, namely the Wt1-creERT2 and the Nr5a1-cre to explore the phenotype of loss of NR2F2. They found in both cases that mice are presenting with undescended testis and major reduction in FLC numbers. They show that NR2F2 has no effect on the amount and expression of the progenitor cells but in its absence, there are less FLC and they are immature.</p><p>The effect of NR2F2 is cell autonomous and does not seem to affect other signalling pathways implemented in Leydig cell development as the DHH, PDGFRA and the NOTCH pathway.</p><p>Overall, this paper is excellent, very well written, fluent and clear. The data is well presented, and all the controls and statistics are in place. I think this paper will be of great interest to the field and paves the way for several interesting follow up studies as stated in the discussion</p><p><bold>Reviewer #2 (Public review):</bold></p><p>The major conclusion of the manuscript is expressed in the title: &quot;NR2F2 is required in the embryonic testis for Fetal Leydig Cell development&quot; and also at the end of the introduction and all along the result part. All the authors' assertions are supported by very clear and statistically validated results from ISH, IHC, precise cell counting and gene expression levels by qPCR. The authors used two different conditional Nr2f2 gene ablation systems that demonstrate the same effects at the FLC level. They also showed that the haplo-insufficiency of Wt1 in the first system (knock-in Wt1-cre-ERT2) aggravated the situation in FLC differentiation by disturbing the differentiation of Sertoli cells and their secretion of pro-FLC factors, which had a confounding effect and encouraged them to use the second system. This demonstrates the great rigor with which the authors interpreted the results. In conclusion, all authors' claims and conclusions are justified by their high-quality results.</p><p><bold>Recommendations for the authors:</bold></p></disp-quote><p>We thank the reviewers for their comments which have improved and strengthened our manuscript. Please see our responses to specific comments below in blue.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>I have several small comments:</p><p>(1) There has been recently a preprint from the Yao lab about the role of NR2F2 is steroidogenic cells (<ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2024.09.16.613312v1">https://www.biorxiv.org/content/10.1101/2024.09.16.613312v1</ext-link>). They performed cKO of NR2F2 using the Wt1creERT2 and found similar results. You should present and discuss this paper in light of your results.</p></disp-quote><p>Estermann et al., report a very similar phenotype of FLC hypoplasia in an independent mouse model of <italic>Nr2f2</italic> conditional mutation. We have now referred to this article in the discussion of our manuscript as suggested.</p><disp-quote content-type="editor-comment"><p>(2) In the introduction I think it is important to mention that the steroidogenic progenitors are derived from Wnt5a positive cells (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35705036/">https://pubmed.ncbi.nlm.nih.gov/35705036/</ext-link>).</p></disp-quote><p>We have mentioned this point in the introduction as suggested.</p><disp-quote content-type="editor-comment"><p>(3) In both models you show a decrease in the number of FLC (60% or 40%) and yet they both present with undescended testis. It is important to discuss the fact that there is no need for a complete ablation of testosterone and INSL3 in order to get cryptorchidism.</p></disp-quote><p>We have mentioned this point in the discussion as suggested.</p><disp-quote content-type="editor-comment"><p>The fact that you get only partial reduction in FLC is likely due to redundancy with additional factors, possibly the ARX like you stated in the discussion and it will be interesting to explore that in the future but is beyond the scope of the current paper.</p></disp-quote><p>We agree with the reviewer, this question could be addressed by analyzing <italic>Arx,Nr2f2</italic> double mutants.</p><disp-quote content-type="editor-comment"><p>(4) In page 8 line 11 you mention data not shown- not sure if this is allowed in the journal .</p></disp-quote><p>The data is now shown in Figure S5A as suggested.</p><disp-quote content-type="editor-comment"><p>(5) In Figure 2- it will be good if you add a schematic model of the mouse strains used as well as the experimental and control mice next to the Tam scheme. Similar scheme should be in figure 3 for Nr5a1-cre.</p></disp-quote><p>We have modified Figures 2 and 3 as suggested.</p><disp-quote content-type="editor-comment"><p>(6) There is a clear and pronounced effect of the testis cords number and size. It will be good if you could qualify testis cord numbers/ diameter in the mutants even if you do not follow in detail the effect on Sertoli cells</p></disp-quote><p>We have quantified testis cords numbers and area in E14.5 Control and Wt1<sup>CreERT2/+</sup>; <italic>Nr2f2flox/flox</italic> testes. This data is now shown in Figure S2M.</p><disp-quote content-type="editor-comment"><p>(7) It will be good to present the undescended testis in the Wt1-cre model in figure 2 and not in the supp figure</p></disp-quote><p>The data is now shown in Figure 2H-I as suggested.</p><disp-quote content-type="editor-comment"><p>(8) Please add labelling of the testis, kidney, bladder, vas deferens in figure 3 N+O and in the Wt1-cre model</p></disp-quote><p>We have added the labels in Figures 2 and 3 as suggested.</p><disp-quote content-type="editor-comment"><p>(9) In figure 5 which present both models- it will be good to use the scheme I suggested before to highlight which results refer to which ko model.</p></disp-quote><p>We have modified Figure 5 as suggested.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>The work presented in this manuscript gave me food for thought. I have always been intrigued by the fact that of the large number of interstitial cells in the testis, a minority differentiate into mature androgen-producing Leydig cells. In other words, how is the number of functional steroidogenic cells defined from a large pool of progenitor cells (ARX and NR2F2 positive ones)? This may have a link with the levels of androgens produced (a kind of feedback control) or the effectiveness of these androgens on the target tissues (i.e.: as spermatogenesis efficiency in adults). In addition, there must be specific signals (probably linked to gonadotropins) that induce the recruitment of Leydig cells from the progenitor pool. Perhaps the genetic models generated in this study could help to address these questions. I leave it to the authors to judge.</p></disp-quote><p>We agree with the reviewer. How NR2F2 (and other factors) integrate extrinsic cues to regulate the recruitment of a subset of interstitial steroidogenic progenitors along the Leydig cell differentiation pathway is a fascinating question beyond the scope of this work.</p><disp-quote content-type="editor-comment"><p>In addition to this reflection, I propose a few minor modifications likely to improve the quality of the manuscript:</p><p>(1) Page 3, lane 3: I suggest to replace &quot;growth&quot; by &quot;differentiation&quot;</p></disp-quote><p>We have modified the text as suggested.</p><disp-quote content-type="editor-comment"><p>(2) Page 3, lane 4: the &quot;scrotum&quot; is missing in the parenthesis. Please add it before &quot;and penis&quot;</p></disp-quote><p>We have modified the text as suggested.</p><disp-quote content-type="editor-comment"><p>(3) Page 5, lanes 21-24: kidney hypoplasia is also evident on Fig S2H (stated in the figure legend). It could be also mentioned in this sentence and it implies &quot;...that NR2F2 function is required for testicular and kidney development.&quot;</p></disp-quote><p>We have modified the text as suggested.</p><disp-quote content-type="editor-comment"><p>(4) Page 5, lanes 28-30. In addition to the reduction in the number of HSD3B-positive cells, HSD3B staining seems clearly more faint in mutant FLC (Fig 2M) compared to adrenal cells on the same section or FLC in control gonads. This fits well with other results on the level of steroidogenic enzymes (Fig 2O) and those presented thereafter (Fig S4 I-J and Fig 5). Perhaps the author could mention this fact.</p></disp-quote><p>We have modified the text as suggested in the results section “NR2F2 is required for FLC maturation” (Page 8).</p><disp-quote content-type="editor-comment"><p>(5) Page 5, lanes 31-34: testicular descent is hugely sensible to INSL3 in the mouse (by contrast with other species where androgens seem to be more critical). I was wondering if you can check a better phenotypic marker for the absence (or reduction) of androgens like the differentiation of epididymides by HE staining or the anogenital distance at birth.</p></disp-quote><p>We have measured the anogenital distance at P0 and P1 as suggested and have included the corresponding graph in Fig. S3P</p><disp-quote content-type="editor-comment"><p>(6) Page 8, lanes 21-22: &quot;HSD3B positive FLC were smaller and more elongated&quot;. It is clear on Fig 5F but not evident on Fig 5D. Could the authors propose another image?</p></disp-quote><p>We have modified Figure 5 as suggested and provide now another example of HSD3B positive FLCs in a <italic>Nr5a1Cre; Nr2f2flox/flox</italic> mutant gonad (Fig. 5D) and the corresponding control littermate (Fig. 5C).</p><disp-quote content-type="editor-comment"><p>(7) Page 14, lane 12: &quot;(arrow in I)&quot; should be &quot;(arrow in H)&quot;</p></disp-quote><p>We have modified the text as suggested. Please note that ACTA 2 expression is now shown in Figure S2 G-H.</p><disp-quote content-type="editor-comment"><p>(8) Page 15, lane 6: &quot;Arrows indicate NR5A1 positive FLC&quot;. There is no arrow on Fig4 C,D; but a kind of scale bar on the enlargement shown in C.</p></disp-quote><p>We have modified Figure 4 as suggested.</p></body></sub-article></article>